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Abstract 
Autophagy is a conserved catabolic process that traffics cellular components to the 
lysosome for degradation. Autophagy is required for cell survival during nutrient 
restriction, but it has also been implicated in programmed cell death. It is associated with 
several diseases, including cancer. Cancer is a disease characterized by aberrant cell 
growth and proliferation. To support this growth, the tumor cell often deregulates several 
metabolic processes, including autophagy. Interestingly, autophagy plays paradoxical 
roles in tumorigenesis. It has been shown to be both tumor suppressive through cell death 
mechanisms and tumor promoting through its cytoprotective properties. However, the 
mechanisms regulating the balance between cell death and cell survival, as well as the 
metabolic consequences of disrupting this balance, are still poorly understood. 
Autophagy functions in both cell survival and cell death during the development of 
Drosophila melanogaster, making it an ideal model for studying autophagy in vivo. My 
research aimed to better understand the regulation and metabolic contribution of 
autophagy during cell death in Drosophila. I found that the Ral GTPase pathway, 
important to oncogenesis, regulates autophagy specifically during cell death in 
Drosophila larval salivary glands. Contrary to previous studies in mammalian cell 
culture, Ral is dispensable for autophagy induced during nutrient deprivation suggesting 
that Ral regulates autophagy in a context-dependent manner. This is the first in vivo 
evidence of Ral regulating autophagy. I found that disrupting autophagy has an extensive 
impact on an organism’s metabolism. Additionally, I found that autophagy in degrading 
tissues is crucial for maintaining the fly’s metabolic homeostasis, and that it may be 
vii 
 
important for resource allocation amongst tissues. This research highlights the 
importance of understanding how pathways regulate autophagy in different cell contexts 
and the metabolic outcomes of manipulating those pathways. This is especially important 
as we investigate which pathways to target therapeutically in an effort to harness 
autophagy to promote cell death rather than cell survival. 
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CHAPTER I 
Introduction 
Autophagy 
Autophagy is an important catabolic process in all eukaryotic cells. There are 
three known types of autophagy: macroautophagy, microautophagy, and chaperone-
mediated autophagy (Klionsky, 2005). Macroautophagy (hereafter referred to as 
autophagy) is the best characterized of the three types, and it involves the sequestration of 
cytoplasmic components and long-lived proteins into lysosomes for degradation. During 
autophagy, an isolation membrane sequesters cytoplasmic material, and it elongates to 
form a double-membrane vesicle, the autophagosome (Figure 1-1). The autophagosome 
traffics to the lysosomal compartment where its outer membrane fuses with lysosomes 
and releases the inner cargo for degradation. Lysosomal permeases then recycle the 
degradation products back to the cytoplasm (Mizushima and Komatsu, 2011). Autophagy 
is an important process for maintaining cell homeostasis, responding to stress, and 
surviving nutrient starvation. 
 
Regulatory pathways  
Several metabolic regulatory factors affect autophagy induction, including 
nutrient availability, insulin signaling, and ATP levels (Meijer and Codogno, 2004). The 
mechanistic target of rapamycin (TOR) plays a central role in autophagy by integrating 
the class I phosphatidylinositol-3-kinase (PI3K) and amino acid signaling pathways 
(Wullschleger et al., 2006). When nutrients are available, class I PI3K activates TOR, 
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which represses autophagy by phosphorylating Atg13. This hyperphosphorylation 
reduces the affinity of Atg13 for Atg1, decreasing the kinase activity of Atg1 and 
inhibiting autophagy (Noda and Ohsumi, 1998; Kamada et al., 2000). During nutrient 
starvation, TOR activity is reduced, relieving its repression of Atg1, and autophagy is 
induced. Increased autophagy contributes to cell survival by producing amino acids and 
fatty acids that are used by the tricarboxylic acid (TCA) cycle to generate ATP (Lum et 
al., 2005). 
The origin of the autophagic membrane is not completely understood and remains 
a subject of debate (Juhasz and Neufeld, 2006). In yeast, autophagy proteins gather at the 
Pre-Autophagosomal Structure (PAS) near the vacuole (Mizushima, 2007a). In animal 
cells, a PAS-like structure has never been observed. Some studies suggest that in 
mammalian cells, the autophagosomal membrane originates from the endoplasmic 
reticulum (ER) (Dunn, 1990; Axe et al., 2008). In addition, more recent research suggests 
that autophagosome formation involves membrane derived from the mitochondria or the 
plasma membrane (Hailey et al., 2010; Ravikumar et al., 2010).  
Formation of the autophagosomal membrane requires phosphorylation of 
phosphatidylinositol. In yeast, this is accomplished by a class III PI3K complex 
consisting of Vps30/Atg6 /Beclin1, Vps34/ class III PI3K, Atg14, and Vps15 (Kametaka 
et al., 1998; Kihara et al., 2001; Suzuki et al., 2001). Atg6 also forms a complex required 
for the vacuolar protein sorting (VPS) pathway in yeast, which consists of Atg6, Vps34, 
Vps15, and Vps38 (Kihara et al., 2001). The Beclin1-Vps34 complex in mammalian cells 
is similar to the Atg6-Vps34 complex in yeast, however, it contains additional regulators, 
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including UVRAG, Bif1, Ambra1, and Barkor (Liang et al., 2006; Fimia et al., 2007; 
Takahashi et al., 2007; Sun et al., 2008). As in yeast, it has been suggested that Beclin1 
forms at least two distinct complexes in animal cells that play different roles in 
membrane trafficking (Itakura et al., 2008). 
 
Autophagosome formation 
Genetic studies in yeast have identified several Atg genes that are required for 
autophagy (Tsukada and Ohsumi, 1993; Thumm et al., 1994; Harding et al., 1995, 1996; 
Klionsky et al., 2003). Atg9, Atg2, and Atg18 make up one complex of the core 
autophagy machinery. Atg9 is the only essential autophagy protein known to have an 
integral membrane domain and is thought to be important for sourcing membrane during 
early autophagosome formation (Lang et al., 2000; Noda et al., 2000; Yamamoto et al., 
2012). In yeast, Atg9 is found on single-membrane vesicles and upon autophagy 
induction, the Atg9-containing vesicles assemble and form the PAS (Yamamoto et al., 
2012). Atg18 is a member of the WD-repeat protein interacting with phosphoinositides 
(WIPI) protein family. Atg18 binds to Atg2 forming a complex that is recruited to the 
autophagosomal membrane. The recruitment of this complex to the autophagosome is 
dependent on Atg18 binding PI3P and is facilitated by Atg1-dependent phosphorylation 
of Atg9 (Obara et al., 2008; Rieter et al., 2013; Papinski et al., 2014). The Atg18-Atg2 
complex regulates the recycling of Atg9 from the PAS (Reggiori et al., 2004; Suzuki et 
al., 2007). 
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Many of the Atg genes are involved in two conserved ubiquitin-like conjugation 
systems that are required for autophagosome formation, Atg12 and Atg8 (LC3 in 
mammals) (Klionsky and Emr, 2000; Ohsumi, 2001). Atg12 and Atg8 are both activated 
by the E1-like enzyme Atg7. Atg12 is then transferred to the E2-like enzyme Atg10. 
Finally, Atg12 is conjugated to Atg5 and forms a complex with Atg16 on the isolation 
membrane (Mizushima et al., 1998, 1999; Shintani et al., 1999; Tanida et al., 1999; 
Kuma et al., 2002). Atg8 is transferred to the E2-like enzyme Atg3 and is then 
conjugated to the phospholipid anchor phospatidylethanolamine (PE) (Ichimura et al., 
2000). This final conjugation results in the anchoring of Atg8-PE to the isolation 
membrane and is thought to regulate the elongation of the isolation membrane 
(Nakatogawa et al., 2007). In addition to Atg7 and Atg3, Atg8 modification requires 
Atg4, a cysteine protease that processes Atg8 before conjugation and cleaves Atg8 from 
PE once the autophagosome has fused with the lysosome (Ichimura et al., 2000). Since 
Atg8 remains on the membrane throughout autophagosome maturation, it is a useful 
marker of autophagosomes (Klionsky et al., 2012). 
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Figure 1-1 
 
Figure 1-1. Regulation of autophagy. Autophagy is a catabolic process by which 
organelles and cytoplasmic proteins are degraded. Induction of autophagy results in the 
formation of an isolation membrane, which expands and closes around cytoplasmic 
material, forming the double-membraned autophagosome. The autophagosome traffics to 
the lysosome where it docks and fuses, releasing its inner membrane and its contents. The 
autophagosome contents are degraded by lysosomal enzymes and recycled back to the 
cytoplasm through permeases. Autophagy is regulated by nutrient status through the 
modulation of TOR signaling. TOR inhibits autophagy by repressing the Atg1-Atg13 
interaction that is required for autophagy initiation. The Atg6 (Beclin1)-ClassIII PI3K 
complex, the Atg12 and Atg8 ubiquitin-like conjugation systems, and the 
Atg9/Atg18/Atg2 complex are required for autophagosome formation. 
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Autophagy and membrane trafficking 
 Autophagy is one of several vesicle trafficking processes that occurs in the cell. 
Typically, vesicle trafficking processes are studied separately; however, it is becoming 
increasingly evident that many of these processes are intimately connected and that they 
share molecular machinery. As described earlier, Atg6/Beclin1 in mammalian cells and 
yeast is involved in multiple membrane trafficking processes depending on which 
proteins it associates with. In yeast, Atg14 localizes to the PAS and recruits Atg6-Vps34 
to the PAS, while Vps38 localizes to endosomes and is required for targeting Atg6-Vps34 
to endosomes (Obara et al., 2006) Recently, it has been shown that Vps15, Atg6 and 
Vps34 are required for endocytosis in Drosophila (Juhasz et al., 2008; Shravage et al., 
2013; Anding and Baehrecke, 2015). The role of Vps15, Atg6 and Vps34 in endocytosis 
may be autophagy-independent since this complex is also found on early endosomes in 
the endocytic pathway (McKnight et al., 2014). In support of this, Atg1 is not required 
for endocytosis in Drosophila (Shravage et al., 2013), suggesting that even though 
endocytosis and autophagy share some molecular machinery, these two processes may 
not be dependent on each other, at least in the Drosophila fat body.  
Although autophagy is traditionally thought of as a degradative process, there is 
mounting evidence that it has non-degradative roles in both conventional and 
unconventional protein secretion (Deretic et al., 2012). Autophagy has been implicated in 
the regulated secretion of many factors, including cathepsin K from osteoclasts, lysozyme 
from paneth cells, and ATP from cancer cells (Cadwell et al., 2008; DeSelm et al., 2011; 
Michaud et al., 2011). Autophagy is also involved in the constitutive secretion of IL-6 
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and IL-8 during oncogene-induced senescence in mammalian cells through its 
involvement in the TOR-autophagy spatial coupling compartment (TASCC) (Narita et 
al., 2011).  Finally, several unconventionally secreted proteins, including Acb1 in yeast, 
IL-1, IL-18, and HMGB1 in mammalian cells have been shown to require autophagic 
machinery for their export (Duran et al., 2010; Dupont et al., 2011). Interestingly, Atg1, 
as well as Atg6, Vps34 and Vps15 have recently been shown to be required for protein 
secretion in Drosophila salivary glands (Shravage et al., 2013; Anding and Baehrecke, 
2015). Since Atg1 is involved in secretion but not endocytosis, this may suggest that 
autophagy and protein secretion are more dependent on each other than autophagy and 
endocytosis. Future studies of the core autophagic machinery and its involvement in 
endocytosis and secretion should provide valuable insight into the interconnectedness of 
these membrane trafficking processes. 
 
The Ral/exocyst effector complex and autophagy 
 One regulatory factor that has been implicated in multiple membrane trafficking 
processes is the Ral small GTPase. Ral is highly conserved amongst metazoans and is a 
member of the Ras superfamily of small GTPases (Wennerberg et al., 2005). Small 
GTPases are enzymes that cycle through active and inactive states by binding GTP and 
hydrolyzing GTP to GDP. The cycling of GTPases is regulated by two classes of 
proteins, GTPase activating proteins (GAPs) and guanine nucleotide exchange factors 
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(GEFs). GAPs facilitate GTP hydrolysis effectively turning off the GTPase, while GEFs 
catalyze exchange of GDP with GTP, turning on the GTPase (Figure 1-2). 
 
Figure 1-2 
 
Figure 1-2. Schematic of small GTPases. Small GTPases cycle between two states, the 
GDP-bound inactive and the GTP-bound active states. Small GTPases have intrinsic 
GTPase activity that hydrolyzes GTP to GDP and inorganic phosphate (Pi). Guanine 
nucleotide exchange factors (GEFs) catalyze the exchange of GDP to GTP to activate 
small GTPases. In turn, GTPase-activating proteins (GAPs) facilitate the hydrolysis of 
GTP to GDP to inactivate small GTPases. 
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Mammalian Ral has two isoforms, RalA and RalB. Human RalA and RalB share 
82% amino acid sequence identity with the majority of their sequence differences 
occurring in the C-terminal membrane targeting sequence (Gentry et al., 2014). 
Drosophila melanogaster has a single Ral ortholog that shares 72% identity with human 
RalA and 71% identity with human RalB (Figure 1-3). The GTPase domain accounts for 
most of the protein and includes GTP binding motifs and an effector binding loop. Within 
the effector binding loop, there are two highly conserved switches, switch I and switch II, 
that change conformation upon GTP binding. Most Ral effectors bind to either one or 
both of these switches (van Dam and Robinson, 2006). 
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There are several pathways that can activate Ral (Figure 1-4). The major pathway 
for Ral activation is the Ras signaling pathway. Upon growth factor binding to receptor 
tyrosine kinase, the small GTPase Ras is activated. Ras in turn stimulates its downstream 
effectors, including PI3K, Raf, and RalGEF. The RalGEF then activates Ral as described 
above.  Ral can also be activated by Ca2+/calmodulin signaling. Calmodulin binds and 
activates Ral in a Ca2+ -dependent manner, and this binding requires prenylation of the C-
terminal of Ral (Wang and Roufogalis, 1999; Clough et al., 2002; Sidhu et al., 2005). 
Finally, Aurora-A kinase can phosphorylate RalA at Ser-149 (absent in RalB) to 
stimulate RalA activation (Wu et al., 2005; Lim et al., 2010). 
Ral has many downstream effectors that it interacts with when in its active GTP 
bound state. Briefly, one lesser known Ral effector is the Y-box transcription factor 
ZONAB. Active RalA interaction with ZONAB increases with increased cell density and 
releases ZONAB transcriptional repression (Frankel et al., 2005). This may provide a 
link between Ral and transcription, however, it remains unclear which genes are turned 
on. 
Of the Ral effectors, the ones involved with membrane trafficking are the best 
characterized. Ral-binding protein (RalBP1/RLIP76) was the first Ral effector to be 
discovered and was identified by screens for proteins that bound with activated RalA 
(Cantor et al., 1995; Jullien-Flores et al., 1995; Park and Weinberg, 1995). RalBP1 
provides a link between Ral and a variety of cell processes. RalBP1 contains a RhoGAP 
domain and regulates the activity of Cdc42 and Rac, small GTPases that modulate the 
actin cytoskeleton (Cantor et al., 1995; Jullien-Flores et al., 1995; Park and Weinberg, 
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1995). RalBP1 also interacts with several proteins that regulate endocytosis and signal 
transduction. The Eps homology domain-containing proteins Reps1 and POB1 interact 
with the C-terminus of RalBP1 and are involved in epidermal growth factor (EGF) 
receptor endocytosis (Yamaguchi et al., 1997; Nakashima et al., 1999). Additionally, the 
N-terminus of RalBP1 interacts with the AP2 complex which regulates clathrin-mediated 
endocytosis from the plasma membrane (Jullien-Flores et al., 2000).  
The other well-known effectors of Ral are Sec5 and Exo84, two members of the 
exocyst complex (Moskalenko et al., 2002, 2003). The exocyst is critical to exocytosis by 
spatially targeting and tethering secretory vesicles to the plasma membrane. It consists of 
eight conserved protein subunits that were first identified in yeast: Sec3, Sec5, Sec6, 
Sec10, Exo70, and Exo84 (Novick et al., 1980; TerBush et al., 1996; Guo et al., 1999). 
Sec5 and Exo84 competitively bind to active Ral (Jin et al., 2005). Through its 
interaction with either Sec5 or Exo84, Ral is thought to regulate the assembly of the full 
exocyst complex from two separate subcomplexes (Moskalenko et al., 2003). The 
exocyst is known to interact with a variety of other GTPases, however, its regulation by 
Ral is interesting as Ral is specific to metazoans. This suggests that the exocyst requires 
additional regulation and may have more functions in higher eukaryotes than in yeast.  
Recent studies in mammalian tissue culture have described a novel function for 
the interaction of RalB with the exocyst: regulation of stress-induced autophagy 
(Bodemann et al., 2011; Martin et al., 2014). Through biochemical studies, a model has 
been proposed whereby Sec5 and Exo84 subcomplexes serve as scaffolds for ULK1 and 
the Beclin1-Vps34 complex. Under nutrient replete conditions, a Sec5 exocyst 
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subcomplex serves as a scaffold for active mTORC1, ULK1, and Vps34, suppressing 
autophagy. Upon nutrient starvation, RalB is activated and is required for both the 
disassembly of the autophagy machinery from Sec5 and reassembly of the active 
autophagy machinery on an Exo84 exocyst subcomplex (Bodemann et al., 2011). This 
suggests that RalB and the exocyst are important for early steps during autophagy 
initiation, however it remains unknown whether Ral and the exocyst are general 
regulators of all autophagy or if they specifically regulate stress-induced autophagy. 
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Figure 1-4 
 
Figure 1-4. Schematic of Ral signaling. Ral is activated downstream of Ras signaling. 
Ral can also be activated by Ca2+/calmodulin signaling and Aurora-A Kinase. The 
various intracellular roles of Ral are mediated by its different downstream effectors. 
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Drosophila as a model for studying the interface between steroid signaling, 
nutrition and growth during development   
Drosophila development provides a useful system for studying the coordination 
of cell growth, division, and death that is necessary for the animal to reach its proper size. 
Fly development is regulated by the steroid 20-hydroxyecdysone (ecdysone), and insulin 
and insulin-like growth factor signaling. These pathways are also known to regulate 
autophagy in different contexts; however, the coordination of steroid, insulin signaling, 
and autophagy is poorly understood. Recent studies have investigated the relationship 
between ecdysone and growth factor signaling in flies (Colombani et al., 2005; Layalle et 
al., 2008), and understanding how these two pathways coordinate with each other may 
provide insight into how autophagy fits into this dynamic to facilitate animal 
homeostasis.    
 
Steroid signaling 
 During development, Drosophila transitions through many different stages, and 
these transitions are signaled by pulses of the steroid hormone ecdysone (Riddiford et al., 
2000; Thummel, 2001). Drosophila begins life as an embryo, and approximately 1 day 
after egg lay, they hatch as 1st instar larvae. The larvae feed and grow for approximately 
3.5 days, and they molt twice during this period to become 2nd instar larvae 24 hours after 
hatching and 3rd instar larvae 48 hours after hatching. After the larval period, the animal 
stops feeding and a high titer pulse of ecdysone triggers puparium formation. This 
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ecdysone pulse also induces the programmed cell death of the larval midgut (Lee et al., 
2002a). Prepupal development lasts for 12 hours, and another peak in ecdysone titer 
triggers the prepupal-pupal transition and initiates programmed cell death of the larval 
salivary glands (Lee et al., 2003). Pupal development lasts for 3.5 days, after which the 
adult animal ecloses. A remarkable transformation occurs during this final developmental 
period; the tissues necessary to the  feeding larva degrade through histolysis and are 
replaced by growing tissues that will be necessary to the walking, flying, and reproducing 
adult (Figure 1-5).   
 
Figure 1-5 
 
Figure 1-5. Drosophila development. The life cycle of the fly from embryo to adult 
takes place over approximately 10 days in a laboratory setting. The first half of this time 
is spent feeding and growing, while the second half is spent in a non-feeding transitional 
state. See the text for more details. The larval to pre-pupal and pre-pupal to pupal 
ecdysone peaks are indicated by the grey boxes. 
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Ecdysone signaling has been studied extensively in the larval salivary glands of 
Drosophila. The pulses of ecdysone regulate stage and tissue-specific developmental 
pathways through a transcriptional hierarchy (Thummel, 1995) (Figure 1-6). Ecdysone 
signals by binding its receptor which is a heterodimer of two nuclear receptors, ecdysone 
receptor (EcR) and ultraspiracle (USP) (Koelle et al., 1991; Yao et al., 1992; Thomas et 
al., 1993). The ecdysone receptor complex activates transcription of the early genes; 
these include Broad Complex (BR-C), E74A, E75, and E93 (Burtis et al., 1990; Segraves 
and Hogness, 1990; DiBello et al., 1991; Baehrecke and Thummel, 1995). The early 
genes then activate transcription of the late genes, which are thought to function more 
directly in the regulation of developmental processes. In the salivary glands, the FTZ-F1 
orphan nuclear receptor is expressed during the mid-prepupal dip in ecdysone titer 
(Lavorgna et al., 1993). During the ecdysone peak that triggers salivary gland 
degradation, the ecdysone receptor complex and FTZ-F1 function together to re-induce 
transcription of BR-C, E74A, and E75 and to activate transcription of the stage-specific  
early gene, E93 (Woodard et al., 1994; Baehrecke and Thummel, 1995; Broadus et al., 
1999). FTZ-F1, BR-C, E74A, and E93 are all necessary for the proper degradation of 
larval salivary glands (Restifo and White, 1991; Broadus et al., 1999; Jiang et al., 2000; 
Lee et al., 2000). E93 may have a more prominent role in autophagic cell death than the 
other early genes as it is also appears to be required for autophagosome formation in the 
dying larval midgut (Lee et al., 2002a).   
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Figure 1-6 
 
Figure 1-6. Genetic regulation of ecdysone-induced autophagy in Drosophila 
salivary glands. At 10 hours after puparium formation, there is a rise in ecdysone titer, 
and ecdysone binds to its heterodimeric receptor which consists of EcR and USP. The 
ecdysone receptor complex functions together with FTZ-F1 to induce transcription of 
the early genes; BR-C, E74A, and E93. The early genes activate transcription of many 
late genes involved in signaling, cellular organization, apoptosis, and autophagy. 
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Growth and nutrient utilization 
 Growth regulation at the cellular, tissue, and organismal level is critical for proper 
size development in all multi-cellular organisms, and it is affected by several 
environmental factors including nutrient availability (Mirth and Riddiford, 2007). In 
Drosophila, the feeding larva grows an astounding amount, increasing its size by ~200-
fold during the 3.5 day period (Church and Robertson, 1966).  Without this accumulation 
of body mass, the fly may have reduced reproductive success as an adult, or it may not 
even be able to survive metamorphosis from the larva to adult.  
For the adult fly to reach its proper size, the larva must pass three weight 
checkpoints. The first checkpoint occurs near the 2nd instar to 3rd instar molt, and is called 
the threshold size for metamorphosis (Zhou et al., 2004). This size assessment determines 
whether the next molt will be a larval or metamorphic molt (Nijhout, 1975). The second 
checkpoint is the minimal viable weight which is the minimum body mass that is 
necessary to complete larval and pupal development in the absence of nutrients (Bakker, 
1959). The final checkpoint, critical weight, occurs during the last larval stage (Nijhout 
and Williams, 1974; Nijhout et al., 2014). Reaching critical weight ensures that the 
animal will pupate within a certain amount of time regardless of nutrient availability 
(Bakker, 1959; Robertson, 1963; Mirth and Riddiford, 2007; Nijhout et al., 2014).  Of 
these three size assessment checkpoints, critical weight is the most studied and best 
understood in Drosophila.  
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Once larvae reach their critical weight, environmental factors have a large impact 
on adult size. Larvae that starve before they achieve critical weight will delay their 
development until the nutrient supply improves. If nutrients are still abundant after larvae 
reach critical weight, they will continue to accumulate body mass (Mirth and Riddiford, 
2007; Tennessen and Thummel, 2011). On the other hand, if post-critical weight larvae 
starve, they will stop growing in size. Since these starved larvae have reached their 
critical weight, they will enter metamorphosis within a similar time frame as fed larvae, 
but they will be smaller and will mature into smaller adults than the fed animals. This 
suggests that the mechanisms that regulate development and puparium formation must 
coordinate with nutrient utilization.     
 The endocrine cascade that follows critical weight achievement was originally 
described in the tobacco hookworm, Manduca sexta (Nijhout and Williams, 1974; 
Truman and Riddiford, 1974). Briefly, once larvae reach critical weight, juvenile 
hormone (JH) titers drop, causing a release of prothoracicotropic hormone (PTTH), 
which signals to the prothoracic gland (PG) to produce ecdysone. However, this function 
of JH does not seem to be conserved in Drosophila, suggesting that critical weight is 
determined through another mechanism (Stern and Emlen, 1999; Nijhout et al., 2014).  
Recent studies have elucidated some of the mechanisms required for critical 
weight assessment in Drosophila. One study showed that the Drosophila insulin receptor 
(InR), which has a conserved role in nutrition-dependent growth in animals, affects 
growth differently in pre-critical weight and post-critical weight larvae (Shingleton et al., 
2005). Before larvae reach critical weight, InR signaling influences developmental timing 
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but not larval growth. In contrast, InR activity affects final body size but not 
developmental timing in post-critical weight larvae. This is consistent with the 
observations in starved larvae discussed above. Several other studies showed that in 
Drosophila the size of the PG affects developmental rate and body size (Caldwell et al., 
2005; Colombani et al., 2005; Mirth et al., 2005). They did this by manipulating insulin-
dependent growth in the PG. When PG growth was suppressed by the expression of 
PTEN, a phosphatase that antagonizes class I PI3K activity, dominant negative class I 
PI3K, or dominant negative Ras, the larvae were larger than controls and had a longer 
developmental period. Conversely, larvae with an enlarged PG due to either class I PI3K 
or Ras activation, initiated metamorphosis earlier than controls and thus the adults were 
smaller. Interestingly, the effects of growth in the PG appear to be specific to the insulin 
signaling pathway and not to cell size increase in general. In the study done by 
Colombani et al, they increased PG size by manipulating two other growth pathways in 
addition to PI3K; Myc and cyclin D/Cdk4. Although activation of these two genes 
increased the size of the PG, they had no effect on pupal or adult size (Colombani et al., 
2005). 
It is clear from these studies that tissue growth coordinates with developmental 
timing through InR signaling; however, the signals that regulate this have not been well 
studied. Recently, two independent groups performed screens to identify molecules that 
couple tissue growth with developmental timing, and identified a novel Drosophila 
insulin-like peptide (dilp), dilp8 (Colombani et al., 2012; Garelli et al., 2012). Perturbing 
growth of larval imaginal discs either through damage or tumor promotion, causes a 
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delay in the time to pupariation, allowing the imaginal discs to reach their correct size 
(Simpson et al., 1980; Poodry and Woods, 1990; Menut et al., 2007; Smith-Bolton et al., 
2009). dilp8 is highly induced in imaginal discs with growth perturbations (Colombani et 
al., 2012; Garelli et al., 2012). Importantly, knockdown of dilp8 in tissues with abnormal 
growth prevents the delay in pupariation, suggesting that it is required for the coupling of 
tissue growth and developmental timing. Expression of dilp8 in imaginal discs is also 
sufficient to delay the onset of metamorphosis, which can be overcome by feeding larvae 
ecdysone (Garelli et al., 2012). Additionally, co-culture experiments reveal that ecdysone 
production in the ring gland is suppressed in response to Dilp8 produced by imaginal 
discs (Colombani et al., 2012). Taken together, these results suggest that Dilp8 is 
secreted by the imaginal discs and remotely acts on the ring gland to suppress ecdysone 
production and delay development. How Dilp8 suppresses ecdysone is not known, but it 
may signal through the InR pathway.  
It has been shown that insulin signaling and ecdysone regulate each other 
antagonistically (Caldwell et al., 2005; Colombani et al., 2005; Mirth et al., 2005). A 
recent study has demonstrated a role for the nuclear cofactor, dDOR in the relationship 
between insulin signaling and ecdysone. They show that dDOR is a coactivator of EcR, 
and that its expression is down-regulated by insulin signaling via the inhibition of FOXO 
activity (Francis et al., 2010; Mauvezin et al., 2010). In addition, ecdysone induces 
translocation of dFOXO into the nucleus, promoting dDOR expression, which further 
activates EcR and initiates a feed-forward loop. Intriguingly, dDOR knockout flies have a 
salivary gland degradation defect, and DOR has been shown to regulate autophagy in 
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both mammalian and Drosophila cells (Francis et al., 2010; Mauvezin et al., 2010). 
These results provide one of the few mechanisms that integrate insulin signaling, 
ecdysone, and autophagy in the context of development. 
 
Autophagy and Drosophila development 
 Most autophagy studies have been conducted in either yeast or mammalian cell 
culture. While these studies have been essential to our understanding of the genetic 
mechanisms that regulate autophagy, there is little known about the impact of autophagy 
on the homeostasis of multi-cellular organisms. It would be interesting to understand how 
autophagy in different cell contexts, such as cell growth, cell survival, and cell death, 
affects the organism as a whole. 
Drosophila is an ideal system for studying autophagy in a multi-cellular 
organism. The steroid and growth factor signaling pathways that regulate autophagy are 
similar in flies and humans. Importantly, Atg genes and their regulators are highly 
conserved between flies and humans (Baehrecke, 2003). In contrast to mammalian 
systems, Drosophila has little genetic redundancy and has single copies for most genes in 
the autophagic pathway and its regulatory pathways. In addition, autophagy is induced in 
Drosophila tissues in response to either nutrient starvation or the steroid hormone 
ecdysone (Lee and Baehrecke, 2001; Lee et al., 2002a; Rusten et al., 2004).  
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Autophagy in growth and nutrient utilization 
 Autophagy is critical for proper nutrient utilization during Drosophila larval 
development. In the fly, the major storage site for glycogen, lipids, and proteins is the fat 
body, an organ that shares attributes with both mammalian adipose tissue and liver. The 
fat body provides an excellent model for studying the mechanisms that regulate 
autophagy. When larvae are deprived of amino acids, autophagy is induced in the fat 
body, and this starvation-induced autophagy is regulated by TOR signaling (Scott et al., 
2004). It has been shown that inactivation of TOR signaling either by a TOR null mutant 
or by manipulating upstream regulators of TOR induces autophagy in the fat body of 
feeding larvae. On the other hand, activation of either TOR or class I PI3K suppresses 
starvation-induced autophagy in the fat body (Scott et al., 2004). These results, taken 
together with the result that constitutive expression of PI3K in the fat body causes 
reduced viability during starvation (Britton et al., 2002), suggest that proper regulation of 
the class I PI3K signaling pathway is necessary for autophagy to promote survival during 
starvation.  
 In addition to being necessary for survival during starvation, autophagy may have 
a critical role in lipid metabolism of the Drosophila fat body. In mammalian cells, it has 
been shown that there is a connection between autophagy and lipolysis as well as lipid 
storage. Singh et al demonstrated that triglycerides (TG) and lipid droplet (LD) proteins 
associated with both autophagosomes and lysosomes. Moreover, inhibition of autophagy 
in mouse liver cells led to increased TGs and LDs in vitro and in vivo, while increased 
autophagy led to decreased TGs and LDs in vitro (Singh et al., 2009). Their data suggests 
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that lipid accumulation during autophagy inhibition is a result of blocked lipolysis. By 
contrast, it has been shown that loss of either Atg5 or Atg7 in mouse adipocytes leads to 
reduced lipid accumulation and impaired adipocyte differentiation (Baerga et al., 2009; 
Zhang et al., 2009). Similar results were obtained in a recent study of Drosophila larval 
fat body. Atg7 loss-of-function mutants had smaller lipid droplets in the fat body, 
indicating a lipid accumulation defect (Wang et al., 2012). One possible explanation for 
the discrepancies between these studies is that autophagy may affect lipid metabolism in 
a tissue-specific manner. It would be interesting to further investigate the relationship 
between autophagy and lipid metabolism and how it is regulated in different tissues. 
 Wang et al. (2012) provided insight into the relationship between lipid 
metabolism and autophagy. Members of the Rab small GTPase family have been 
associated with lipid droplets, and are known to participate in many cellular processes, 
including endocytosis, exocytosis, autophagosome formation, lysosome formation, and 
signaling transduction (Liu et al., 2007; Stenmark, 2009; Zehmer et al., 2009). In a screen 
for Rab proteins that affect lipid droplet size, Wang et al found 18 Rab proteins that 
either increased or decreased lipid droplet size (Wang et al., 2012). They focused on 
Rab32, and showed that as well as having smaller lipid droplets, Rab32 mutants have 
impaired autophagy in the fat body. Importantly, Rab32 localized on autophagosomes, 
but not lipid droplets, suggesting that its effect on lipid droplet size is due to regulation of 
autophagy rather than a direct effect on lipid droplets. Since different Rab proteins have 
different effects on lipid droplet size, investigating the remaining Rab proteins might 
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shed some light on the regulation of the relationship between autophagy and lipid 
metabolism.  
 Autophagy is also induced in the fat body and other tissues, including the salivary 
glands and mid gut during development in response to rises in ecdysone titer. This 
developmental autophagy is induced during the wandering larval stage and 
metamorphosis at times when the animal is not feeding, suggesting that autophagy may 
play an important role in survival and even tissue growth during non-feeding periods 
(Lee and Baehrecke, 2001; Lee et al., 2002a; Rusten et al., 2004). In the fat body, 
programmed autophagy is induced in response to ecdysone late during the third larval 
stage. This induction requires the down-regulation of class I PI3K signaling (Rusten et 
al., 2004), suggesting that regulation of the class I PI3K pathway is involved in both 
starvation-induced autophagy and developmental autophagy. 
 Studies in Drosophila have further investigated the relationship between 
autophagy and growth. TOR is a key regulator of cell growth that was first implicated in 
the regulation of autophagy when rapamycin, a TOR inhibitor, was shown to induce 
autophagy (Blommaart et al., 1995). TOR represses autophagy through phosphorylation 
of Atg1 (Kamada et al., 2000; Scott et al., 2007). In Drosophila larval fat body, over-
expression of Atg1 inhibits cell growth through a negative feedback mechanism on TOR. 
Conversely, Atg1 mutant cells with reduced TOR signaling have increased growth (Scott 
et al., 2007). These results suggest that autophagy is a negative regulator of cell growth. 
Interestingly, it has been shown that inhibiting autophagy in a TOR null background 
enhances the TOR mutant phenotypes, including reduced growth rate, smaller cell size, 
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and decreased survival (Scott et al., 2004). This suggests that under these conditions, in 
contradiction to its role as a negative regulator of growth, autophagy is necessary to 
promote cell survival and maintain growth.    
 The relationship between autophagy and growth signaling has also been studied in 
the context of degrading tissues during Drosophila metamorphosis. Growth arrest is 
required for the induction of autophagy in degrading salivary glands (Berry and 
Baehrecke, 2007). This growth arrest is regulated by the class I PI3K pathway. 
Maintaining growth in the salivary glands through expression of activated Ras, Akt, or 
the class I PI3K catalytic subunit Dp110, inhibits autophagy and gland degradation. In 
addition, co-expression of a dominant negative TOR with either Ras or Dp110 partially 
suppresses the overgrowth phenotypes and the salivary gland degradation defects (Berry 
and Baehrecke, 2007). These data suggest that cell growth regulators signal through TOR 
to inhibit autophagy and prevent salivary gland degradation. Furthermore, over-
expression of Atg1, which induces autophagy, suppresses the Dp110 persistent salivary 
gland phenotype, while Atg loss-of-function mutations cause persistent salivary glands 
(Berry and Baehrecke, 2007), indicating that both growth arrest and autophagy are 
required for proper salivary gland degradation. 
 A recent study has observed a similar relationship between growth arrest and 
autophagy during midgut programmed cell death in Drosophila. In the midgut, as in the 
salivary glands, growth arrest occurs before programmed cell death induction (Denton et 
al., 2012a). When cell growth in the midgut is maintained by expression of either 
activated Ras or Dp110, autophagy is suppressed and midgut degradation is delayed 
28 
 
(Denton et al., 2012a). These results indicate a role for growth arrest in midgut 
programmed cell death. In contrast, inhibition of growth by the expression of PTEN or 
TSC1/TSC2, negative regulators of class I PI3K signaling, results in smaller midguts and 
premature autophagy induction. This growth inhibition can be suppressed by knockdown 
of either Atg1 or Atg18 in a PTEN or TSC1/TSC2 expressing background (Denton et al., 
2012a). Interestingly, knockdown of Atg genes alone in the midgut causes persistent 
PI3K growth signaling and a significant delay in midgut degradation. These results 
suggest that in the midgut, growth and autophagy have a reciprocal relationship as in the 
salivary glands; however, there is also a feedback mechanism by which autophagy down-
regulates class I PI3K signaling. The nature of this feedback mechanism is unknown and 
deserves future investigation.          
 There has been some recent progress on the study of how cell growth arrest is 
regulated in dying salivary glands. The evolutionarily conserved Warts (Wts)/Hippo 
(Hpo) signaling pathway is an important negative regulator of cell growth that functions 
through the inactivation of Yorkie (Yki), a transcriptional coactivator and positive 
regulator of growth (Huang et al., 2005).  Loss-of-function mutations in the Wts 
pathway, or over-expression of Yki lead to tissue overgrowth (Huang et al., 2005). 
Importantly, wts is required for growth arrest and autophagy induction in degrading 
salivary glands (Dutta and Baehrecke, 2008). Disruption of this pathway by mutations in 
wts and hpo or knockdown of sav and mats prevents salivary gland degradation (Dutta 
and Baehrecke, 2008). Surprisingly, over-expression of Yki fails to inhibit salivary gland 
degradation, suggesting that Wts regulates salivary gland growth in a Yki-independent 
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manner. Significantly, wts mutants cause persistent class I PI3K signaling in salivary 
glands, and knockdown of chico or expression of dominant-negative TOR suppress the 
wts cell death defects (Dutta and Baehrecke, 2008). These data suggest that Wts regulates 
salivary gland cell growth in a class I PI3K-dependent manner. However, Wts does not 
have a common role in programmed cell death. Despite the clear requirement for class I 
PI3K signaling in the regulation of cell growth and cell death in the midgut, knockdown 
of wts does not affect midgut morphology or degradation (Denton et al., 2012a).  
 
Autophagy and cell death 
 Programmed cell death is a highly conserved and genetically regulated 
fundamental biological process. During development, cell death is required for tissue 
pattern formation and to maintain tissue homeostasis. Cell death also functions to remove 
abnormal or damaged cells. Schweichel and Merker (1973) described three major types 
of cell death during mammalian development based on morphology and involvement of 
the lysosomal compartment. Type I cell death, or apoptosis, is characterized by caspase 
activation, cell shrinkage, cytoplasmic blebbing, nuclear and DNA fragmentation, and 
engulfment by a phagocyte where the lysosome of the engulfing cell degrades the dying 
cell (Kerr et al., 1972). In contrast to apoptosis, type II cell death, or autophagic cell 
death, requires little or no help from phagocytes, and the dying cell is degraded by its 
own lysosome. Type III cell death, or necrosis, is the least common form of cell death, 
and it has no known lysosomal involvement. 
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 Type II cell death is observed in a variety of organisms. The plant, Arabidopsis, 
requires type II cell death for the formation of tracheary elements (Kwon et al., 2010). 
Type II cell death has also been observed in several tissues during mammalian 
development, including regression of the corpus luteum and involution of mammary and 
prostate glands (Clarke, 1990). Type II cell death is best characterized in insects and has 
been observed in several tissues during development, including dying flight muscles of 
the Hawkmoth Manduca sexta (Lockshin and Williams, 1965), and degrading salivary 
glands and midgut in Drosophila (Lee and Baehrecke, 2001; Lee et al., 2002a). Although 
autophagosomes are present in dying cells with type II morphology, the role of autophagy 
in cell death remains controversial (Levine and Yuan, 2005; Denton et al., 2012b). 
 Studies of dying larval tissues during Drosophila metamorphosis have provided 
evidence for a role of autophagy in programmed cell death. As described above, a peak in 
ecdysone titer triggers salivary gland degradation during metamorphosis (Figure 1-7). 
Several Atg genes exhibit increased transcription in salivary glands in response to the rise 
in ecdysone, including Atg2, Atg3, Atg4, Atg5, Atg7, and Atg18 (Gorski et al., 2003; Lee 
et al., 2003). Additionally, mutations in transcription factors downstream of the ecdysone 
receptor inhibit transcription of Atg-related genes and prevent proper salivary gland cell 
death (Lee et al., 2003), suggesting that ecdysone-induced autophagy promotes cell 
death. It was not until recently though that the function of autophagy in cell death was 
rigorously tested in vivo. Mutations in Atg8, Atg18, Atg2, or Atg3, or decreased function 
of Atg1 all result in incomplete degradation of the larval salivary glands (Berry and 
Baehrecke, 2007). In addition, knockdown of Atg3, Atg6, Atg7, or Atg12 specifically in 
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the salivary glands leads to incomplete gland destruction, suggesting that autophagy 
functions in a tissue-autonomous manner in these dying cells (Berry and Baehrecke, 
2007). Moreover, mis-expression of Atg1 in the salivary glands induces autophagy and 
leads to premature gland degradation in a caspase-independent manner (Berry and 
Baehrecke, 2007). This is in contrast to previous work which showed that over-
expression of Atg1 in the fat body induces cell death that depends on caspase function 
(Scott et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
32 
 
Figure 1-7 
 
Figure 1-7. Drosophila salivary gland degradation. Formation of the white pre-pupa is 
triggered by a rise in the steroid hormone ecdysone and is designated as 0hr. A second 
ecdysone peak triggers the pre-pupal to pupal transition that occurs 10-12hr apf. 
Histological sections of salivary gland degradation in wild type flies. At 12hr apf, 
salivary glands (black circles) are large and vacuolated and caspases are activated. By 
14hr apf, salivary glands (black circles) have condensed and autophagy has been 
initiated. By 16hr apf, salivary glands (black circles) are completely degraded. Genetic 
mutants are screened for defects in salivary gland degradation at 24hr apf. 
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There is also mounting evidence for a role of autophagy during programmed cell 
death of the larval midgut. Similar to salivary glands, larval midgut destruction is 
triggered by a peak in ecdysone titer at the end of larval development. The dying midguts 
have increased autophagosome formation, and inhibition of autophagy by loss-of-
function mutations in Atg2 or Atg18 or knockdown of either Atg1 or Atg18 severely 
delays midgut removal (Denton et al., 2009). Additionally, over-expression of Atg1 in 
the larval midgut is sufficient to induce autophagy and premature degradation (Denton et 
al., 2012a). Surprisingly, caspases are active, but they are not required for removal of the 
midgut (Denton et al., 2009, 2010), indicating that there is a complex relationship 
between autophagy and caspases in this tissue.  
Autophagy and caspases have a complex relationship that may be context-
dependent. During salivary gland degradation, the rise in ecdysone titer triggers increased 
transcription of not only Atg genes, but also the proapoptotic genes, rpr and hid, caspases, 
the BCL-2 family member buffy, and ark, the fly Apaf-1 homologue (Jiang et al., 1997; 
Dorstyn et al., 1999; Lee et al., 2002b). Caspase activation occurs in the glands, but 
expression of the caspase inhibitor p35 only partially inhibits salivary gland degradation 
(Lee and Baehrecke, 2001). Additionally, ark mutants have a partial salivary gland 
degradation defect, but autophagy occurs normally, suggesting that ark may function 
downstream or parallel to autophagy in programmed cell death (Akdemir et al., 2006; 
Mills et al., 2006). Significantly, inhibiting both caspases and autophagy by expressing 
p35 in salivary glands of Atg18 loss-of-function mutants or with dominant negative Atg1, 
results in increased persistence of the salivary glands (Berry and Baehrecke, 2007). These 
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results suggest that autophagy and caspases function in parallel during salivary gland cell 
death. Many of the components of the apoptotic machinery are also up-regulated in dying 
midguts. Despite the presence of high levels of caspase activity, p35 expression or 
genetic ablation of the canonical caspase activation pathway has no effect on midgut 
degradation (Denton et al., 2009). This is in contrast to what has been observed in 
salivary glands, and it would be interesting to study what causes these distinct differences 
between how programmed cell death is executed in these two tissues. 
 Although these in vivo studies indicate a role for autophagy in programmed cell 
death, the mechanistic differences that determine whether autophagy will support cell 
survival or cell death are not clear. Recently, Draper (Drpr), the Drosophila homologue 
of C. elegans engulfment receptor CED-1, and other components of the engulfment 
pathway were shown to be required for induction of autophagy during cell death 
(McPhee et al., 2010). Null mutations in drpr and salivary gland-specific knockdown of 
drpr prevent induction of autophagy and cause persistent salivary glands. Expression of 
Atg1 in drpr mutants is sufficient to rescue the salivary gland degradation defect, 
indicating that Drpr functions upstream of autophagy. Surprisingly, clonal analysis of 
degrading glands reveals that Draper functions in a cell-autonomous manner, as there is 
only a reduction of autophagy in the drpr mutant cells. Interestingly, knockdown of drpr 
in the fat body does not affect starvation-induced autophagy, implicating drpr as the first 
known factor to regulate autophagy’s role in cell death but not cell survival (McPhee et 
al., 2010). It would be interesting to further investigate how Drpr is regulated in salivary 
glands, and why an engulfment receptor is functioning cell-autonomously.    
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Autophagy, Ral, and cancer 
 The role of autophagy in cancer is unclear. Just as it has dual roles in cell death 
and cell survival in the fly, autophagy has been shown to both suppress tumor initiation 
and promote tumor growth (Mizushima et al., 2008a). Defects in core autophagy genes 
have been linked to tumorigenesis. Mice with monoallelic loss of Beclin1 (Atg6) have an 
increased incidence of spontaneous lymphomas and solid tumors (Qu et al., 2003), 
suggesting that it is a haploinsufficient tumor suppressor. Consistent with these results, a 
single copy of Beclin1 is often deleted in breast, ovarian, and prostate cancers (Aita et al., 
1999). One possible mechanism for the tumor suppressive function of autophagy is the 
removal of dysfunctional mitochondria (mitophagy) (Green et al., 2011; Takahashi et al., 
2013). Damaged mitochondria produce excess reactive oxygen species (ROS) which can 
damage DNA, causing genome instability and enabling tumor progression. Moreover, 
removal of damaged mitochondria by autophagy may counteract the metabolic 
reprogramming that occurs during tumorigenesis (Green et al., 2011). It is possible that 
autophagy functions to suppress tumor initiation, but is then required for further tumor 
progression (Galluzzi et al., 2015). In support of this hypothesis, mice with mosaic 
deletion of Atg5 or liver-specific deletion of Atg7 develop benign liver adenomas, 
however, the tumors do not progress to malignant carcinoma (Takamura et al., 2011). 
 By contrast, the cytoprotective properties of autophagy can promote tumor 
progression by aiding in tumor cell survival. In a mouse model for hepatocellular 
carcinoma metastasis, downregulation of either Beclin1 or Atg5 suppressed lung 
metastasis by diminishing the anoikis-resistance of tumor cells (Peng et al., 2013). This 
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suggests that autophagy contributes to tumor progression by protecting cells against 
anoikis. Additionally, autophagy has been shown to contribute to therapy resistance (Hu 
et al., 2012). Radiation causes accumulation of autophagosomes in resistant cancer cells, 
while downregulation of autophagy genes sensitizes these cells to radiation therapy (Apel 
et al., 2008). This suggests that in some cases, autophagy may be a therapeutic target in 
conjunction with traditional therapies. 
There is accumulating evidence that autophagy’s role in cancer is context 
dependent. In a mouse model of oncogenic Kras-driven pancreatic ductal 
adenocarcinoma (PDAC), autophagy’s role in tumor progression is dependent on p53 
(Rosenfeldt et al., 2013). Mice expressing oncogenic Kras and lacking Atg5 or Atg7 
develop pancreatic intraepithelial neoplasias (PIN) that do not progress to PDAC. By 
contrast, embryonic loss of p53 reverses the block of tumor progression caused by 
autophagy deficiency (Rosenfeldt et al., 2013).  Interestingly, in a recent mouse model of 
Kras-driven PDAC that more closely resembles PDAC progression in humans, sensitivity 
to autophagy inhibition is independent of p53 status (Yang et al., 2014). In this model, 
rather than embryonic homozygous deletion of p53 in the pancreas contributing to PDAC 
progression, the pancreas is heterozygous for p53, and loss of heterozygosity (LOH) of 
the wild type p53 allele occurs during PDAC progression (Yang et al., 2014). These 
contrasting results suggest that even the developmental timing of genetic alterations can 
affect how autophagy will function within the cell. Additionally, in Drosophila models of 
tissue ovegrowth, whether autophagy suppresses or promotes overgrowth depends on 
both the genetic background and cell type (Pérez et al., 2014). These results suggest that 
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the context should be carefully considered when determining if and how to 
therapeutically target autophagy. 
It is becoming clear that autophagy is an important component of oncogenic Ras-
driven transformation in a variety of cell contexts (Schmukler et al., 2014). Oncogenic 
RAS mutations occur in 33% of human cancers and are associated with several cancers, 
including lung, colon, and pancreatic (Karnoub and Weinberg, 2008). The regulation of 
autophagy by Ras is convoluted as Ras has several downstream effectors, and they can 
have opposing effects on autophagy. Class I PI3K is a downstream effector of Ras, and as 
discussed above, is a negative regulator of autophagy. This would suggest that Ras is also 
a negative regulator of autophagy. However, there is evidence that oncogenic Ras can 
induce autophagy, and that some Ras-driven tumors, such as PDACs are sensitive to 
autophagy inhibition (Wu et al., 2011; Yang et al., 2014). RalB is activated downstream 
of Ras signaling and is a positive regulator of autophagy.  Additionally, both Ral 
isoforms have been shown to play a variety of roles in Ras-driven tumorigenesis (Gentry 
et al., 2014). For example, RalA is required for tumorigenic growth while RalB is 
required for invasion and metastasis in PDAC cells (Lim et al., 2006). Since Ral is 
important to Ras-driven tumorigenesis and is a positive regulator of autophagy, it may be 
an important factor in tumor cell autophagy. 
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Outstanding questions 
 Organisms require a balance between cell survival and cell death to maintain 
homeostasis, and although in vivo evidence supports a role for autophagy in both cell 
survival and cell death, many fundamental questions remain. Since autophagy is involved 
in both protecting and killing the cell, it is important to determine the mechanisms that 
decide between these cell fates. One possibility is that autophagy selectively depletes a 
cell survival factor or an essential organelle, which leads to cell death (Yu et al., 2006; 
Abeliovich, 2007; Nezis et al., 2010). Another possibility is that there is a threshold of 
autophagic flux that is crossed to promote cell death. Extended growth factor withdrawal 
in apoptotic-resistant mouse cells leads to stress-induced autophagy and eventual death 
by depletion of cellular resources (Lum et al., 2005). Under more physiological 
conditions, degradation of the Drosophila salivary glands and midgut is preceded by an 
increase in both transcription of the Atg genes and autophagosome levels. Additionally, 
mis-expression of Atg1 in several tissues promotes cell demise; supporting the idea that 
excessive autophagy leads to cell death.  However, excessive autophagy might not always 
be enough to kill, and other death factors may be required in addition to autophagy. Cell 
death induced by Atg1 mis-expression in the fat body is caspase-dependent. Furthermore, 
salivary glands require caspases and autophagy, functioning in parallel, to fully degrade 
(Berry and Baehrecke, 2007).  
 Autophagy has been shown to be both an alternative form of cell death in non-
physiological conditions, and a necessary component of cell death in physiological 
contexts; however, why cells die by autophagy is not understood. Apoptosis requires a 
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phagocyte to engulf the dying cell, while autophagic cell death has little or no phagocyte 
involvement. One possibility is that phagocytes have restricted access to the dying cells. 
In Drosophila, the adult midgut forms around the degrading larval midgut isolating the 
dying cells from the rest of the tissues. Similarly, in vitro models of mammary lumen 
formation, where the dying cells are isolated from phagocytes, implicate the necessity of 
both caspases and autophagy for elimination of the dying cells (Debnath et al., 2002; 
Mills et al., 2004). Alternatively, large cells and tissues, such as the giant larval salivary 
glands, may be too big to degrade by phagocytosis alone, and they require autophagy for 
the bulk degradation of their cytoplasm. Finally, autophagy may contribute to nutrient 
resource reallocation and survival in multi-cellular organisms. In yeast and mammalian 
cell culture, autophagy degrades cellular content to produce ATP and resources to protect 
the cell during starvation. Interestingly, autophagic cell death of tissues in Drosophila 
occurs during a time when the animal receives no external nutrients and must rely on its 
nutrient stores for survival and development of adult structures. Furthermore, the 
majority of Atg mutants are pupal lethal, suggesting that autophagy is necessary to 
survive metamorphosis. Thus, although autophagy is killing individual cells and tissues, 
this form of cell death could be promoting organism survival.  
 Here, I investigate the regulation and function of autophagy during salivary gland 
cell death in Drosophila. First, I demonstrate that Ral GTPase and the exocyst regulate 
autophagy in a tissue-specific manner. Second, I describe how autophagy influences 
organismal metabolism during development. My research challenges the existing 
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paradigm of how Ral and the exocyst regulate autophagy and offers insight into how 
autophagy may contribute to life even in a cell death context.  
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CHAPTER II 
Ral GTPase and the Exocyst Regulate Autophagy in a Tissue-Specific 
Manner 
Abstract 
Autophagy is a conserved process that traffics cellular components to the lysosome for 
degradation. In animals, autophagy has been implicated in many processes, including 
age-related diseases, cell survival and cell death. Ral GTPase is an important regulator of 
several vesicle trafficking processes and along with the exocyst has been implicated in 
the regulation of stress-induced autophagy in mammalian cells; however, it remains 
unclear whether Ral is a global regulator of autophagy. Here, we investigate the function 
of Ral in different cellular contexts under physiological conditions in Drosophila 
melanogaster, and find that it is required for autophagy during developmentally regulated 
cell death. Inhibition of Ral blocks autophagy in degrading salivary gland cells, but does 
not affect starvation-induced autophagy in the fat body. Furthermore, knockdown of 
different exocyst subunits has a similar effect, preventing autophagy in dying salivary 
gland cells but not in starved fat body cells. These data provide in vivo evidence that Ral 
and the exocyst regulate autophagy in a context-dependent manner. 
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Introduction 
Macroautophagy (autophagy) is a catabolic process during which cytoplasmic 
components, including organelles and long-lived proteins, are engulfed and trafficked to 
the lysosomal compartment for degradation (Mizushima and Komatsu, 2011). Autophagy 
has been implicated in several diseases, including neurodegeneration and cancer 
(Mizushima et al., 2008b). Autophagy plays dual roles to determine cell fate depending 
on cell context (White, 2012). During stress, such as nutrient deprivation or growth factor 
removal, autophagy promotes cellular homeostasis and survival by recycling cell 
components for energy production (Lum et al., 2005). Alternatively, autophagy has been 
shown to function in developmentally regulated cell death, as in the case of degrading 
larval salivary glands during Drosophila development (Berry and Baehrecke, 2007).  
 Autophagy is regulated by upstream protein and lipid kinase complexes, and these 
complexes in turn influence core ubiquitin-like conjugation pathways that control 
autophagosome formation around cytoplasmic cargoes (Das et al., 2012). The serine 
threonine kinase Atg1 (Ulk1/2 in mammals) complex is under control of mTOR, and this 
is a regulatory complex that integrates nutritional status with the requirement for 
activation of autophagy (Kamada et al., 2000). The Vps34 lipid kinase (class III 
phosphatidylinositol-3-kinase in mammals) complex is required for the formation of 
phosphatidylinositol-3-phosphate (PI3P), and therefore has been implicated in multiple 
vesicle trafficking processes, including autophagy, endocytosis and protein secretion 
(Schu et al., 1993; Stack et al., 1993; Juhasz et al., 2008). 
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 Ral is a member of the Ras superfamily of small GTPases. Ral has a variety of 
downstream effectors and has been implicated in several cellular processes, including 
gene transcription, signal transduction, actin organization, and membrane dynamics 
(Gentry et al., 2014). Two well-characterized Ral effectors are the exocyst components, 
Sec5 and Exo84 (Moskalenko et al., 2002, 2003; Jin et al., 2005). Through its 
interactions with these effectors, Ral plays an important role in vesicle trafficking and 
protein secretion.  Recently, autophagy genes have been implicated in both conventional 
and unconventional protein secretion (Deretic et al., 2012; Shravage et al., 2013). 
Importantly, several regulators of autophagy, including Atg6, Vps34, Atg1, and Vps15, 
have been shown to be required for steroid-induced secretion of glue proteins from 
Drosophila salivary glands (Shravage et al., 2013; Anding and Baehrecke, 2015). The 
requirement of autophagy genes for protein secretion suggests that there may be cross–
talk between the regulatory factors that control these distinct vesicle trafficking 
processes.  
Ral has been implicated in the regulation of stress-induced autophagy (Bodemann 
et al., 2011). Interestingly, through physical interaction studies between RalB and 
Ulk1/Atg1, components of the Vps34 complex, and the Exo84 exocyst sub-complex, a 
model has been proposed for this super complex in the regulation of autophagy 
(Bodemann et al., 2011). This model makes several predictions, including that the Exo84 
sub-complex of the exocyst functions as a positive regulator of autophagy, and that the 
Sec5 sub-complex of the exocyst functions as a suppressor of autophagy. The function of 
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Ral in the control of autophagy has not been investigated in animals under physiological 
conditions, and it remains unclear if Ral is a global regulator of autophagy. 
 Here we demonstrate that Ral, the Ral guanine nucleotide exchange factor (GEF) 
Rgl and components of the exocyst complex are required for proper larval salivary gland 
degradation. We found that Ral and the exocyst function in salivary gland degradation by 
regulating autophagy. In contrast to previous studies, Ral and the exocyst are not 
necessary for autophagy in response to nutrient-deprivation. These results indicate that 
Ral and the exocyst regulate autophagy in a context-dependent manner.   
Results 
Ral and Rgl are required for salivary gland degradation 
Drosophila larval salivary gland cell death is triggered by a rise in steroid at 12 
hours after puparium formation, and the glands are completely degraded by 16 hours after 
puparium formation (Lee and Baehrecke, 2001). A Ral mutant was identified in a screen 
of lethal P-element insertions for persistent larval salivary glands, suggesting that Ral 
could function in salivary glands during their degradation (Wang et al., 2008). We tested 
whether inhibition of Ral in salivary glands would cause a salivary gland degradation 
defect. We found that knockdown of Ral by expression of an RNAi construct targeting 
Ral, ralIR, in salivary glands with the salivary gland-specific driver fkh-GAL4 resulted in 
a degradation defect in 100% of pupae (Figure 2-1A, B). In contrast, 20% of control 
animals lacking the fkh-GAL4 driver had persistent salivary gland material at 24 hours 
after puparium formation (Figure 2-1A, B). Similarly, we found that 90% of pupae with 
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fkh-GAL4 driving a dominant-negative Ral, RalS25N, had a salivary gland degradation 
defect compared to 15% of control pupae with no fkh-GAL4 driver (Figure 2-1C, D). 
Strong Ral loss-of-function mutants are lethal early during development. Therefore, we 
sought to confirm if Ral function is necessary for proper salivary gland degradation using 
weak ral35d hypomorphic mutants (Balakireva et al., 2006). The ral35d mutant was created 
by imprecise excision of the PG89 P-element, leaving two P terminal repeats within the 
first intron of ral (Balakireva et al., 2006). We found that 61% of ral35d mutant pupae 
failed to complete salivary gland degradation, whereas, most heterozygous control pupae 
lack salivary gland material at 24 hours after puparium formation (Figure 2-1E, F). As the 
ral35d mutants had a much weaker phenotype compared to Ral knockdown, we tested Ral 
protein levels in ral35d mutants and animals expressing ralIR. Surprisingly, we found that 
knockdown of Ral using the ubiquitous driver, act-GAL4, led to a similar level of Ral 
protein expression as in the ral35d mutant (Figure 2-2).  Since Ral is a GTPase, we tested 
whether activation of Ral by its GEF, Rgl, was required for salivary gland degradation. 
We found that salivary gland specific knockdown of Rgl resulted in a similar salivary 
gland degradation defect phenotype to both Ral knockdown and dominant-negative Ral 
expression (Figure 2-1G, H). Combined, these data indicate that Ral and its upstream 
activator, Rgl function in salivary glands during degradation. 
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Figure 2-1 
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Figure 2-1. ral and rgl are required for salivary gland degradation (A) Control 
animals (+/w; UAS-ralIR/+), n= 20, and those with salivary gland-specific knockdown of 
ral (fkh-GAL4/w; UAS-ralIR/+), n=20, were analyzed by histology for the presence of 
salivary gland material (black dotted circle) 24 hours after puparium formation. (B) 
Quantification of data from (A). Data are represented as means. Statistical significance 
was determined using a Chi-square test. (C) Control animals (+/w; UAS-ralS25N/+), n= 20, 
and those with salivary gland-specific expression of dominant-negative Ral (fkh-
GAL4/w; UAS-ralS25N/+), n= 20, were analyzed by histology for the presence of salivary 
gland material (black dotted circle) 24 hours after puparium formation. (D) 
Quantification of data from (C). Data are represented as means. Statistical significance 
was determined using a Chi-square test. (E) Control animals (ral35d/+), n= 25, and ral 
hypomorph mutants (ral35d/Y), n= 23, were analyzed by histology for the presence of 
salivary gland material (black dotted circle) 24 hours after puparium formation. (F) 
Quantification of data from (E). Data are represented as means. Statistical significance 
was determined using a Chi-square test. (G) Control animals (+/w; UAS-rglIR/+), n= 19, 
and those with salivary gland-specific knockdown of rgl (fkh-GAL4/w; UAS-rglIR/+), 
n=20, were analyzed by histology for the presence of salivary gland material (black 
dotted circle) 24 hours after puparium formation. (H) Quantification of data from (G). 
Data are represented as means. Statistical significance was determined using a Chi-square 
test. 
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Figure 2-2 
 
Figure 2-2. Ral protein expression in pupae. Protein extracts from wild type 
(CantonS), ubiquitous Ral knockdown (+/w; UAS-ralIR/+; act-GAL4/+), and ral 
hypomorph mutants (ral35d/Y) 0hr white pre-pupae were analyzed by western blotting 
with an anti-hRalB antibody. Anti-tubulin was used as a loading control. Relative 
densities are given below each lane and were determined using ImageJ image analysis 
software. 
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In addition to testing the requirement of ral in dying salivary glands, we also 
tested the sufficiency of ral to induce premature degradation of salivary glands. We did 
this by expressing a constitutively active ral (ralCA) specifically in salivary glands and 
doing histology at 6hr apf, well before glands degradation is initiated. We found that 
salivary glands were present in both control animals lacking the fkh-GAL4 driver and 
animals with fkh-GAL4-driven expression of ralCA at 6hr apf (Figure 2-3A, B). This 
result suggests that ral is not sufficient to induce salivary gland degradation.  
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Figure 2-3 
 
Figure 2-3. Ral is not sufficient to induce early salivary gland degradation. (A) 
Control animals (+/w; UAS-ralCA/+), n= 10, and those with salivary gland-specific 
expression of constitutively active ral (fkh-GAL4/w; UAS-ralCA/+), n=10, were analyzed 
by histology for the presence of salivary gland material 6 hours apf. (B) Quantification of 
data from (A). Statistical significance was determined using a Chi-square test. 
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Ral is required for autophagy in dying salivary gland cells 
The requirement for Ral during salivary gland degradation led us to investigate 
whether Ral functions in previously defined processes that participate in the destruction 
of this tissue. Salivary gland cell death requires both caspases and autophagy for 
complete salivary gland degradation (Berry and Baehrecke, 2007). Caspases and 
autophagy act in an additive and parallel manner to control salivary gland cell death.  
Decreased function of genes in either pathway results in a salivary gland cell fragment 
phenotype that is characterized by diffused cellular fragments that have detached from 
each other.  In contrast, inhibition of both autophagy and caspases results in a more intact 
salivary gland tissue fragment phenotype where the cells are not diffuse and the remnants 
largely retain the shape and structure of the gland (Berry and Baehrecke, 2007).  
We tested whether Ral may function in the same pathway as caspases by 
expressing the caspase inhibitor, p35. Expression of p35 in the ral35d/wild type 
background lead to persistence of salivary gland cell fragments in 57% of pupae and 
gland tissue fragments in 43% of pupae (Figure 2-4A, B). By contrast, expression of p35 
in the hemizygous ral35d mutant background resulted in persistence of cell fragments in 
20% of pupae and gland tissue fragments in 80% of pupae (Figure 2-4A, B). The 
enhanced gland degradation defect phenotype in the ral35d mutants expressing p35 
indicates that Ral functions in an additive manner with caspases. We further tested the 
relationship between Ral and caspases by knocking down Ral in salivary glands and 
assaying for caspase activity by staining for cleaved caspase 3. At 0 hours after puparium 
formation, well before caspases are activated during salivary gland cell death, both 
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control and ralIR-expressing cells have little to no cleaved caspase 3 staining (Figure 2-
4C, E). At 13 hours after puparium formation, after caspases have been activated, both 
control and ralIR-expressing cells have similarly increased staining for cleaved caspase 3 
(Figure 2-4D, E). Taken together, these data indicate that Ral is not required for caspase 
activity in salivary glands, and that Ral and caspases function in parallel during salivary 
gland cell death. 
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Figure 2-4 
 
55 
 
 
56 
 
Figure 2-4. Loss of ral does not affect caspase activity during salivary gland 
degradation (A) ral hypomorph mutants (ral35d/Y;; UAS-p35/+), n= 20, animals with 
salivary gland-specific expression of p35 (ral35d/+;; UAS-p35/fkh-GAL4), n= 21, and ral 
hypomorph mutants with salivary gland-specific expression of p35 (ral35d/Y;; UAS-
p35/fkh-GAL4), n= 20, were analyzed by histology for the presence of salivary gland 
material (black dotted circles) 24 hours after puparium formation. (B) Quantification of 
data from (A). Data are represented as means. Statistical significance was determined 
using a Chi-square test comparing the percentages of gland fragments. (C) Salivary 
glands dissected from 0 hour after puparium formation control animals (+/w; UAS-
ralIR/+) and those with salivary gland-specific knockdown of ral (fkh-GAL4/w; UAS-
ralIR/+) and stained with cleaved Caspase-3 antibody (green) and Hoescht (blue). (D) 
Salivary glands dissected from 13 hour after puparium formation control animals (+/w; 
UAS-ralIR/+) and those with salivary gland-specific knockdown of ral (fkh-GAL4/w; 
UAS-ralIR/+) and stained with cleaved Caspase-3 antibody (green) and Hoescht (blue). 
Scale bars represent 20m. (E) Quantification of data from (C and D). Data are 
represented as means ± SEM; n≥ 10. Statistical significance was determined using a 
Student’s t test. 
 
  
 
 
 
 
 
 
 
 
57 
 
We next investigated whether Ral is required for autophagy. We first asked if the 
salivary gland degradation phenotype of ral35d mutants is enhanced by knocking down 
the autophagy gene, Atg6. We found that 45% of animals expressing Atg6IR had a 
persistent cell fragment phenotype. Similarly, 46% of ral35d mutants expressing Atg6IR 
had a cell fragment phenotype; neither group had any persistence of gland tissue 
fragments (Figure 2-5A, B). The lack of phenotypic enhancement when Atg6IR is 
expressed in the ral35d background is different from the increased persistence of gland 
material that we observed in ral35d mutants expressing p35 (Figure 2-5A, B), and 
suggests that Ral and Atg6 may function in the same pathway. Next, we asked if Ral 
functions upstream of Atg1, a key regulator of autophagy initiation. Mis-expression of 
Atg1 in salivary glands leads to early degradation of the tissue by 6hr apf and can also 
rescue the salivary gland degradation defect at 24hr apf caused by Dp110 mis-expression 
(Berry and Baehrecke, 2007). We tested whether Atg1 mis-expression in salivary glands 
of the ral35d mutant could rescue the mutant’s gland degradation defect. We found that 
37% of the ral35d mutants had persistent salivary gland material, while none of the ral35d 
mutants with salivary gland specific Atg16a expression had a gland degradation defect, 
indicating that Atg1 mis-expression can rescue the ral35d mutant salivary gland 
degradation defect (Figure 2-6). It should be noted that 85% of the animals expressing 
Atg16a in the ral35d background had developmental defects. This is not normally seen 
when we express Atg16a in salivary glands, and it may be due to a non-specific interaction 
with the ral35d mutant. Consistent with our histological data suggesting that Ral functions 
in the autophagic pathway, clonal knockdown of ral function by expression of ralIR in 
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salivary gland cells 14 hours after puparium formation lead to a significant decrease in 
autophagy reporter mCherry-Atg8a  puncta formation when compared to neighboring 
control cells (Figure 2-5C, D). Combined, these data indicate that ral is required for 
autophagy in dying salivary gland cells. 
 Several factors have been identified that regulate autophagy in a dying cell 
context-specific manner (McPhee et al., 2010; Chang et al., 2013; Nelson et al., 2014). 
Since RalB was shown to be required for resource-deprivation-triggered autophagy in 
mammalian cell lines (Bodemann et al., 2011), this prompted us to ask whether Ral is 
required for starvation-triggered autophagy in vivo. We tested this by assaying for 
mCherry-Atg8a puncta formation in fatbodies of starved animals that clonally express 
ralIR. In contrast to what we observed in dying salivary gland cells, fatbodies of starved 
larvae had similar levels of mCherry-Atg8a puncta in both cells expressing ralIR and their 
neighboring control cells (Figure 2-5E, F). This indicates that Ral functions in a context-
specific manner to regulate autophagy, as it is required for autophagy in dying salivary 
gland cells, but it appears to be expendable for starvation-induced autophagy in the 
fatbody.  
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Figure 2-5 
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Figure 2-5. ral is required for autophagy in dying salivary glands, but not for 
starvation-induced autophagy in fat body (A) ral hypomorph mutants (ral35d/Y;; UAS-
atg6IR/+), n= 27, animals with salivary gland-specific expression of atg6IR (ral35d/+;; 
UAS-atg6IR/fkh-GAL4), n= 20, and ral hypomorph mutants with salivary gland-specific 
expression of atg6IR (ral35d/Y;; UAS-atg6IR/fkh-GAL4), n= 24, were analyzed by 
histology for the presence of salivary gland material (black dotted circles) 24 hours after 
puparium formation. (B) Quantification of data from (A). Data are represented as means. 
Statistical significance was determined using a Chi-square test. (C) Salivary glands 
dissected from 14 hour after puparium formation animals expressing mCherry-Atg8a in 
all cells, and ralIR specifically in GFP-marked clone cells (yw, hsflp/w; pmCherry-
Atg8a/UAS-ralIR; act< FRT, cd2, FRT> GAL4, UAS-GFP/+) analyzed for mCherry-
Atg8a puncta. Scale bars represent 20m. (D) Quantification of data from (C). Data are 
represented as means ± SEM; n≥ 10. Statistical significance was determined using a 
Student’s t test. (E) Fat bodies dissected from 4 hour starved animals expressing 
mCherry-Atg8a in all cells, and ralIR specifically in GFP-marked clone cells (yw, hsflp/w; 
pmCherry-Atg8a/UAS-ralIR; act< FRT, cd2, FRT> GAL4, UAS-GFP/+) analyzed for 
mCherry-Atg8a puncta. Scale bars represent 20m. (F) Quantification of data from (E). 
Data are represented as means ± SEM; n≥ 10. Statistical significance was determined 
using a Student’s t test. 
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Figure 2-6
 
Figure 2-6. (A) ral hypomorph mutants (ral35d/Y;; UAS-atg16a/+), n= 30 and ral 
hypomorph mutants with salivary gland-specific expression of atg16a (ral35d/Y;; UAS-
atg16a/fkh-GAL4), n= 20, were analyzed by histology for the presence of salivary gland 
material (black dotted circles) 24 hours after puparium formation. (B) Quantification of 
data from (A). Data are represented as means. Statistical significance was determined 
using a Chi-square test. 
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The exocyst is required for autophagy associated with cell death, not starvation-
induced autophagy 
Ral has several effector proteins, the best characterized are RALBP (or Rlip) 
which is involved in endocytosis, and the exocyst subunits, Sec5 and Exo84 (van Dam 
and Robinson, 2006). The exocyst is an evolutionarily conserved octameric complex 
involved in the tethering of secretory vesicles to the plasma membrane (Heider and 
Munson, 2012). Previous studies in derived mammalian cell lines suggest that Ral 
regulates autophagy through its interactions with Sec5 and Exo84 (Bodemann et al., 
2011; Martin et al., 2014). Since our results indicate that Ral regulates autophagy in a 
context-dependent manner, we wondered if the exocyst could be regulating autophagy in 
a similar way. We first investigated the ability of RNAi against different exocyst subunits 
to inhibit normal exocyst function. At the end of larval development, the salivary gland 
cells secrete a large amount of glue proteins in response to steroid signaling, and the glue 
is extruded at pupariation (0hr apf). Exocytosis of the glue proteins can be monitored 
easily in vivo using a transgenic fusion of the secreted glue protein, Sgs3, and GFP 
(Biyasheva et al., 2001). We tested whether knockdown of exocyst subunits could affect 
glue peptide exocytosis from salivary glands, and identified RNAi strains against sec5, 
sec3, sec8, and exo84 that inhibited secretion (Figure 2-7), indicating that these RNAis 
are functional. In addition, knockdown of ral in the salivary gland led to a similar 
secretion defect (Figure 2-7).  
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Figure 2-7 
 
Figure 2-7. Ral and the exocyst are required for protein secretion in salivary glands 
Salivary glands dissected from 6 hour after puparium formation control animals (fkh-
GAL4/+; Sgs3-GFP/+), and those with salivary gland-specific knockdown of ral (fkh-
GAL4/w; Sgs3-GFP /+; UAS-ralIR/+), sec5 (fkh-GAL4/w; Sgs3-GFP/+; UAS-
sec5IR/+), sec15 (fkh-GAL4/w; Sgs3-GFP/+; UAS-sec15IR/+), sec3 (fkh-GAL4/w; 
Sgs3-GFP/UAS-sec3IR), sec8 (fkh-GAL4/w; Sgs3-GFP/UAS-sec8IR), exo84 (fkh-
GAL4/w; Sgs3-GFP/UAS-exo84IR) analyzed for presence of Sgs3-GFP. The merged 
images are GFP (green), Hoescht (blue) and DIC. 
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We next asked whether the exocyst could regulate starvation-induced autophagy 
in the fly. We tested this by clonally knocking down several exocyst subunits in fatbody 
cells, starving these animals, and then assaying for mCherry-Atg8a puncta formation. 
Similar to our results with ral knockdown (Figure 2-5), we did not observe a difference in 
mCherry-Atg8a puncta formation between control cells and the various exocyst subunit 
knockdown cells (Figure 2-8). Furthermore, when we clonally knocked down the exocyst 
subunits and checked for mCherry-Atg8a puncta formation in the fatbodies of feeding 
animals, we observed no difference (Figure 2-9). Taken together these results suggest that 
similarly to Ral, the exocyst is not required for starvation-induced autophagy in the fly.  
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Figure 2-8 
 
Figure 2-8. The exocyst is not required for starvation-induced autophagy in fat body 
(A, C, E, G, I) Fat bodies dissected from 4 hour starved animals expressing mCherry-
Atg8a in all cells, and (A) sec5IR, (C) sec15IR, (E) sec3IR, (G) sec8IR, (I) exo84IR 
specifically in GFP-marked clone cells (yw, hsflp/w; pmCherry-Atg8a/+; act< FRT, cd2, 
FRT> GAL4, UAS-GFP/+) analyzed for mCherry-Atg8a puncta. (B, D, F, H, J) 
Quantification of data from (A, C, E, G, I). Data are represented as means ± SEM; n≥ 10. 
Statistical significance was determined using a Student’s t test. 
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Figure 2-9 
 
Figure 2-9. Inhibiting the exocyst does not induce ectopic autophagy in fat bodies 
(A, C, E, G, I) Fat bodies dissected from feeding larvae expressing mCherry-Atg8a in all 
cells, and (A) sec5IR, (C) sec15IR, (E) sec3IR, (G) sec8IR, (I) exo84IR specifically in GFP-
marked clone cells (hsflp/w; pmCherry-Atg8a/+; act< FRT, cd2, FRT> GAL4, UAS-
GFP/+) analyzed for mCherry-Atg8a puncta. (B, D, F, H, J) Quantification of data from 
(A, C, E, G, I). Data are represented as means ± SEM; n≥ 10. Statistical significance was 
determined using a Student’s t test. 
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Since the exocyst, like Ral, is not required for starvation-induced autophagy, we 
next asked whether it is required for cell death associated autophagy. We tested this by 
knocking down several exocyst subunits in salivary glands and assaying for mCherry-
Atg8a puncta formation during salivary gland degradation. We found that in dying 
salivary glands from animals with fkh-GAL4 driven expression of either sec5IR, sec15IR, 
sec3IR, sec8IR, or exo84IR, there were significantly fewer mCherry-Atg8a punctae when 
compared to salivary glands from control animals lacking RNAi to any of the tested 
exocyst components (Figure 2-10). These data indicate that the exocyst is required for 
autophagy in dying salivary gland cells. In addition, we tested whether inhibition of the 
exocyst in salivary glands would cause a salivary gland degradation defect. Expression of 
either sec5IR (Figure 2-11A, B) sec15IR (Figure 2-11C, D), sec3IR (Figure 2-11E, F), 
sec8IR (Figure 2-11G, H) or exo84IR (Figure 2-11I, J) resulted in a significantly higher 
percentage of animals with a salivary gland degradation defect when compared to their 
control animals. These results suggest that the exocyst is necessary for proper salivary 
gland degradation by autophagy during Drosophila development. 
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Figure 2-10 
 
Figure 2-10. The exocyst is required for autophagy in dying salivary gland cells (A) 
Salivary glands dissected from 14 hour after puparium formation (top left) control (fkh-
GAL4/+; pmCherry-Atg8a/+), and those with salivary gland-specific knockdown of 
(middle left) sec5 (fkh-GAL4/w; pmCherry-Atg8a/+; UAS-sec5IR/+), (bottom left) sec15 
(fkh-GAL4/w; pmCherry-Atg8a/+; UAS-sec15IR/+), (top right) sec3 (fkh-GAL4/w; 
pmCherry-Atg8a/UAS-sec3IR), (middle right) sec8 (fkh-GAL4/w; pmCherry-Atg8a/UAS-
sec8IR), (bottom right) exo84 (fkh-GAL4/w; pmCherry-Atg8a/UAS-exo84IR) analyzed for 
mCherry-Atg8a puncta. The merged images are mCherry (red), Hoescht (blue) and DIC. 
(B) Quantification of data from (A). Data are represented as means ± SEM; n≥ 10. 
Statistical significance was determined using a Student’s t test (** p< 0.001, *** p< 
0.0001). 
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Figure 2-11 
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Figure 2-11. The exocyst is required for salivary gland degradation (A) Control 
animals (+/w; UAS-sec5IR/+), n= 19, and those with salivary gland-specific knockdown 
of sec5 (fkh-GAL4/w; UAS-sec5IR/+), n=20, were analyzed by histology for the presence 
of salivary gland material (black dotted circle) 24 hours after puparium formation. (B) 
Quantification of data from (A). Data are represented as means. Statistical significance 
was determined using a Chi-square test. (C) Control animals (+/w; UAS-sec15IR/+), n= 
20, and those with salivary gland-specific expression sec15 (fkh-GAL4/w; UAS-
sec15IR/+), n= 20, were analyzed by histology for the presence of salivary gland material 
(black dotted circle) 24 hours after puparium formation. (D) Quantification of data from 
(C). Data are represented as means. Statistical significance was determined using a Chi-
square test. (E) Control animals (+/w; UAS-sec3IR/+), n= 20, and those with salivary 
gland-specific expression sec3 (fkh-GAL4/w; UAS-sec3IR/+), n= 20, were analyzed by 
histology for the presence of salivary gland material (black dotted circle) 24 hours after 
puparium formation. (F) Quantification of data from (E). Data are represented as means. 
Statistical significance was determined using a Chi-square test. (G) Control animals (+/w; 
UAS-sec8IR/+), n= 20, and those with salivary gland-specific knockdown of sec8 (fkh-
GAL4/w; UAS-sec8IR/+), n=19, were analyzed by histology for the presence of salivary 
gland material (black dotted circle) 24 hours after puparium formation. (H) 
Quantification of data from (G). Data are represented as means. Statistical significance 
was determined using a Chi-square test. (I) Control animals (+/w; UAS-exo84IR/+), n= 
19, and those with salivary gland-specific knockdown of exo84 (fkh-GAL4/w; UAS-
exo84IR/+), n=20, were analyzed by histology for the presence of salivary gland material 
(black dotted circle) 24 hours after puparium formation. (J) Quantification of data from 
(I). Data are represented as means. Statistical significance was determined using a Chi-
square test. 
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Discussion 
In this study, we investigated the role of Ral GTPase in the regulation of 
autophagy in vivo and demonstrated that Ral regulates autophagy in the context of 
developmentally programmed cell death. Our data indicate that the exocyst, a 
downstream Ral effector, is also required for developmentally programmed cell death.  
 Previous studies have implicated the Ral/exocyst effector complex in the 
regulation of autophagy (Bodemann et al., 2011; Martin et al., 2014). In mammalian 
cells, RalB is proposed to regulate starvation-induced autophagy through binding of an 
Exo84 subcomplex of the exocyst. In contrast, we found that neither Ral nor the exocyst 
have an observable role in autophagy triggered by nutrient deprivation in vivo. This could 
be due to the apparent cell-type specificity in which Ral regulates autophagy. 
Additionally, our data contradicts the idea of Ral regulating autophagy through distinct 
exocyst subcomplexes. When we knocked down the different exocyst subunits in salivary 
glands, we observed a similar inhibition of pmCherry-Atg8a puncta formation across all 
subunits, suggesting that the exocyst may function as a whole complex during autophagic 
cell death. In addition, knockdown of Sec5, a key component of the so-called “autophagy 
suppression complex” (Bodemann et al., 2011), failed to cause premature autophagy in 
the fly fatbody (Figure 2-9). These discrepancies could be due to either organism 
differences or differences in the regulation of autophagy depending on context; exocyst 
subcomplexes could regulate starvation-induced autophagy while the octameric exocyst 
complex regulates autophagic cell death.  
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 It remains unclear why Ral regulates autophagy in a context-dependent manner. 
Ral can be activated by Ras or Rap via its Ral-GEF or by Ca2+/calmodulin binding (Hofer 
et al., 1994, 1998; Kikuchi et al., 1994; Wolthuis et al., 1998; Wang and Roufogalis, 
1999; Mirey et al., 2003). Our data indicate that the Ral-GEF, Rgl is necessary for 
salivary gland cell death, however, this does not preclude Ca2+/calmodulin binding from 
being involved. Several studies have linked calcium signaling to autophagy and recent 
results indicate that calmodulin functions downstream of IP3 signaling during salivary 
gland cell death, but not during starvation-induced autophagy in the fatbody (Decuypere 
et al., 2011; Nelson et al., 2014). It could be possible that in the context of cell death, Ral 
is activated by both Ral-GEF and Ca2+/calmodulin binding and potentiates these signals 
to promote autophagy. 
 The Ral/exocyst effector complex is an important spatiotemporal regulator of 
several membrane trafficking processes.  Our findings indicate a previously unknown 
role for the Ral/exocyst effector complex in the regulation of autophagy that is involved 
in cell death. Importantly, we have shown that Ral and the exocyst regulate autophagy in 
a context-dependent manner, and question a global role for these factors in their 
regulation of autophagy in animals. Given recent interest in the targeting of Ral (Yan et 
al., 2014) and autophagy (Cheng et al., 2013) for cancer therapy, it will be important to 
understand how Ral regulates autophagy in a variety of cell contexts. 
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Material and Methods 
Drosophila Strains 
We used the following fly stocks: Canton-S as wild-type control, fkh-GAL4, act-GAL4, 
w; Sgs3-GFP (Bloomington Drosophila Stock Center), yw,hs-Flp; pmCherry–Atg8a; 
act>CD2>GAL4, UAS-GFP/TM6B, fkh-GAL4; pmCherry-Atg8a. For loss of function 
studies, we used ral35d provided by J. Camonis. For RNAi studies we used the following 
stocks from the Vienna Drosophila RNAi Center (VDRC): UAS-ralIR VDRC 
Transformant ID (TID) 43622, UAS-rglIR TID 23639, UAS-sec5IR TID 28873, UAS-
sec15IR TID 35162, UAS-sec3IR TID 35806, UAS-sec8IR TID 45032, UAS-exo84IR TID 
108650. For ectopic expression studies, we used UAS-ralS25N, UAS-p35, UAS-ralCA and 
UAS-Atg16a (Bloomington Drosophila Stock Center). 
Histology 
Staged animals were placed in a dissection dish containing PBS, and their posterior end 
was cut using dissecting scissors exposing the inside of the animal. The pupae were fixed 
in 1 ml of 80% ethanol, 4% formaldehyde, 5% acetic acid, 1% glutaraldehyde (FAAG) in 
a 1.5 ml centrifuge tube overnight at 4°C. Pupae were dehydrated by removing FAAG, 
then incubated at room temperature with 1 ml of 80% ethanol for 10min, 85% ethanol for 
15min, 90% ethanol for 20min, 100% ethanol for 25min, 100% ethanol for 75min, 
xylenes for 25min, and xylenes for 75min. Pupae were transferred using a paint brush to 
a scintillation vial containing approximately 20 paraplast x-tra chips (McCormick 
Scientific 39503002) and 2 ml xylenes. The scintillation vial was incubated overnight at 
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45°C. The wax/xylenes solution was decanted, melted paraplast x-tra was added to vials, 
and samples were incubated at 55°C. Wax changes were repeated two more times over 1 
day. Pupae and wax were poured into paper boats used for paraffin histology, pupae were 
oriented ventral side down using toothpicks, and wax was allowed to solidify overnight. 
Square blocks were cut around each pupa leaving approximately 0.5cm of space around 
the pupa. Blocks with embedded pupa were sectioned using a microtome set to 7m. 
Ribbons of sections were floated on water on a microscope slide on a slide warmer set to 
45°C. When the sectioning was complete, the water was removed with a paper towel, and 
the slides were incubated overnight on the slide warmer. Slides were placed in a staining 
rack and hydrated, stained, and dehydrated in staining dishes using the following series: 
first xylenes for 3min, second xylenes for 3min, first 100% ethanol for 3min, second 
100% ethanol for 3min, 90% ethanol for 3min, 70% ethanol for 3min, running tap water 
for 5min, Weigert’s Hematoxylin for 5min, running tap water for 5min, Pollak trichrome 
for 7min, distilled water for 10sec, 0.2% glacial acetic acid in distilled water for 10sec, 
70% ethanol for 3min, 90% ethanol for 3min, second 100% ethanol for 3min, first 100% 
ethanol for 3min, second xylenes for 3min, and first xylenes for 3min. Slides were dried 
and cover slips were mounted with approximately 1 l Permount for each mm2 of cover 
slip area. 
Protein extracts and western blotting 
White pre-pupae were collected, washed with PBS, homogenized with a pestle in 
Laemmli buffer (0.1% glycerol, 2%SDS, 0.125 M Tris (pH6.8), 0.05% -
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mercaptoethanol, and 0.05% bromo-phenol blue) at 60l Laemmli buffer/ pupae, and 
boiled for 5min at 100C. Precision Plus Protein Dual Color Standard (BIO-RAD) and 
lysates were loaded on an Any kD Mini-PROTEAN TGX precast polyacrylamide gel 
(BIO-RAD #456-9033) and separated at 180V. Proteins were transferred to a 0.45m 
Immobilon-P membrane (Millipore) following standard procedures. Membrane was cut 
between 37kDa and 25 kDa, blocked in 5% non-fat milk in PBS with 1% Tween 20 for 
1hr at room temperature, washed in PBS containing 1% Tween 20 at room temperature 
and incubated with primary antibodies overnight at 4°C. Primary antibodies used were 
mouse anti--Tubulin (1:50) (Developmental Studies Hybridoma Bank) on the top half of 
the membrane and rabbit anti-hRalB (1:1000) (abcam) on the bottom half of the 
membrane. Next day the membrane halves were washed in PBS containing 1% Tween 20 
at room temperature and incubated with secondary antibodies for 1hr at room 
temperature. Secondary antibodies used were HRP-goat anti-mouse (1:2000) on the top 
half and HRP-goat anti-rabbit (1:5000) on the bottom half. The membrane halves were 
then washed and developed using ECL detection reagents 1 and 2 (Amersham) and 
exposed to film. 
Immunostaining and microscopy 
For immunostaining, salivary glands were dissected in PBS and fixed overnight in 4% 
formaldehyde in PBS at 4°C. They were blocked in PBS, 1% BSA, and 0.1% tween 
(PBSBT) and incubated with rabbit anti-cleaved caspase-3 (1:400; Cell Signaling 
Technology) overnight at 4C. Then salivary glands were washed in PBSBT for 2 hours at 
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room temperature, incubated with Alexa Fluor 488 (1:1000; abcam) for 2 hours at room 
temperature, and washed for 1 hour in PBSBT. Salivary glands were mounted in 
Vectashield (Vector Laboratories). For mCherry-Atg8a analysis, salivary glands and fat 
bodies were dissected from animals staged at 25°C in PBS and mounted in 50% glycerol 
in PBS containing 2µM Hoescht stain. mCherry-Atg8a puncta were quantified using 
ImageJ software. All imaging was performed on a Zeiss Axiophot II microscope.  
Induction of cell clones 
To induce RNAi-expressing cell clones, yw,hs-Flp; pmCherry–Atg8a; act>CD2>GAL4, 
UAS-GFP/TM6B virgins were crossed to RNAi transgenic males. Overnight egg lays 
were obtained at 25°C. The embryos were heat shocked at 37°C for 15 min.  
Protein secretion assay 
White pre-pupae were staged at 25°C for 6hr. Salivary glands were dissected in PBS, 
fixed with 4% formaldehyde for 2min, and washed twice with PBS.  Salivary glands were 
mounted in 50% glycerol in PBS containing 2M Hoescht. 
Starvation 
Feeding third instar larvae either remained in the food (fed), or were removed from the 
food and placed in a moist Petri dish for 4hr (starved) at 25°C. 
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CHAPTER III 
Dying to Grow 
Abstract 
Autophagy is a conserved catabolic process responsible for the sequestration and 
trafficking of cytosolic material destined for lysosomal-mediated degradation. It is 
critical for maintaining cellular metabolic homeostasis and has been implicated in both 
cell survival and cell death. Despite autophagy’s importance in several metabolic 
diseases, including cancer, how it affects metabolism in vivo has been poorly studied. 
Drosophila melanogaster provides a unique closed system for studying the effects of 
autophagy. During metamorphosis, Drosophila tissues undergo massive remodeling, and 
autophagy is required for the degradation of several larval tissues. Here, we utilize 
Drosophila to investigate how inhibiting autophagy affects metabolic homeostasis in 
vivo. We find that animals mutant for atg18 have a marked change in their metabolic 
profile compared to control animals, including increased lactate production. Furthermore, 
inhibition of autophagy in individual tissues causes a rise in organismal lactate levels. 
Finally, we find that inhibiting autophagy by class I PI3K activation in larval salivary 
glands causes defects in adult structure growth. Taken together, these results suggest that 
autophagy in certain tissues affects metabolism non-autonomously, and that autophagy 
may be involved in resource allocation amongst tissues. 
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Introduction 
Autophagy is a highly conserved catabolic process. During autophagy, an isolation 
membrane sequesters cytoplasmic components, and it elongates to form a double-
membraned vesicle, the autophagosome.  The autophagosome traffics to the lysosome 
where it fuses and releases its inner membrane and cargo into the lysosome for 
degradation and recycling (Mizushima, 2007b).  Autophagy is an important process for 
maintaining cell homeostasis, responding to stress, and a survival mechanism during 
starvation.  Mutations in autophagy (atg) genes are involved in several disorders 
including neurodegeneration, diabetes, and cancer (Shintani and Klionsky, 2004). 
Several metabolic factors affect levels of autophagy, including nutrient availability, 
insulin, and ATP levels (Meijer and Codogno, 2004).  The target of rapamycin (TOR) 
plays a central role in autophagy and nutrient homeostasis by integrating the Class III 
PI3K and amino acid signaling pathways (Wullschleger et al., 2006).  Under normal 
conditions, amino acid signaling leads to the recruitment of TOR to the lysosome through 
the Ragulator-Rag complex (Sancak et al., 2010). TOR then represses autophagy by 
phosphorylating Atg13.  This hyperphosphorylation reduces Atg13’s affinity for Atg1, 
decreasing the kinase activity of Atg1 and inhibiting autophagy (Noda and Ohsumi, 
1998; Kamada et al., 2000).  Nutrient withdrawal causes TOR inactivation, leading to 
autophagy induction.  Increased autophagy contributes to cell survival by producing 
amino acids and fatty acids that are used by the tricarboxylic acid cycle (TCA) to 
generate ATP (Lum et al., 2005). The restoration of cellular amino acid levels also leads 
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to the recruitment of TOR to autophagolysosomes, where it then promotes the 
reformation of primary lysosomes (Yu et al., 2010). 
Most autophagy studies use yeast or mammalian cell culture, therefore little is known 
about the impact of autophagy on nutrient homeostasis in intact animals where 
catabolism of cells and tissues may influence bioenergetics non-autonomously to 
maintain homeostasis or support growth. An example of autophagy potentially affecting 
cells non-autonomously is the proposed ‘autophagic tumor stromal model’. In this model, 
metabolites derived from autophagy in the tumor stromal compartment are used by 
cancer cells to drive tumor growth (Martinez-Outschoorn et al., 2010b). The supporting 
evidence for this model comes from work that has been done using xenograft models and 
co-culture of derived cell lines (Chiavarina et al., 2010; Martinez-Outschoorn et al., 
2010a; Avena et al., 2013). An in vivo model would provide valuable insights into how 
autophagy in one compartment could affect metabolism of another compartment. 
In animals, organism and tissue size are influenced by feeding during growth phases.  
In Drosophila, growth occurs during the 3.5 day larval period, and adult size is 
determined by the onset of metamorphosis as pupae do not feed.  During metamorphosis, 
Drosophila tissues undergo massive remodeling.  Most larval tissues including the fat 
body, midgut, muscle, and the salivary glands are destroyed by programmed cell death 
mechanisms, including cell death with autophagy (Lee and Baehrecke, 2001; Lee et al., 
2002a; Rusten et al., 2004; Berry and Baehrecke, 2007). Interestingly, the adult structures 
develop during the 3.5 day pupal stage in the absence of feeding, suggesting a 
requirement for resource reallocation.  This closed system of metamorphosis is an ideal 
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model for studying the role of autophagy in nutrient utilization in an animal.  We 
hypothesize that metabolites derived from autophagy in dying larval tissues contribute to 
the regulation of bioenergetics and nutrient homeostasis during Drosophila 
metamorphosis. 
Here we demonstrate that loss of autophagy causes global changes in organism 
metabolism during metamorphosis. We found that animals mutant for the autophagy 
gene, atg18, have a metabolic shift towards a more glycolytic metabolism. Inhibition of 
autophagy in specific larval tissues also causes a shift to a more glycolytic metabolism. 
Additionally, inhibiting growth arrest and autophagy through class I PI3K activation in 
larval salivary glands affects the development of adult structures. These results indicate 
that autophagy in degrading larval tissues can affect organismal metabolic homeostasis, 
and it may play an important role in resource allocation during the extensive remodeling 
that occurs during development.  
Results 
atg18 mutants have altered metabolite profiles  
To understand the effect autophagy has on organismal metabolism, we performed 
an unbiased metabolomics analysis of control and autophagy mutant animals at 24 hours 
after puparium formation (apf). Many of the atg genes are essential and mutants are lethal 
during either the embryonic or larval stages. For this study, we used an atg18 mutant 
because atg18 is part of the core autophagic machinery, and although the homozygous 
atg18KG03090 mutant is larval lethal, this mutant allele with Df(3L)Exel6112 (Df6112) is 
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viable through most of pupal development.  We identified 284 biochemical compounds 
using mass spectrometry-based global biochemical profiling. We found that atg18 
mutants possess 176 and 159 biochemical compounds that were significantly different to 
those in wild type and control heterozygous atg18/wild type pupae, respectively, with 
134 common compounds that were significantly different. Of the common biochemical 
compounds, 33 were increased and 101 were decreased in atg18 mutant animals 
compared to the controls (Figure 3-1). These increased and decreased compounds 
represent changes in multiple metabolic pathways (Table 3-1), suggesting that inhibition 
of autophagy by atg18 mutation causes a global shift in organism metabolism during 
metamorphosis. 
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Figure 3-1 
 
Figure 3-1. Biochemical changes in atg18 mutant (atg18KG03090/Df6112) animals compared 
to wild type (CantonS) and heterozygous atg18 control (atg18KG03090/+) animals. 
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In order to better understand the general contribution of autophagy to metabolism 
during development, we conducted principal component analysis (PCA). PCA is a 
dimensional reduction technique commonly used for replicate analysis that captures the 
variance of a high dimension dataset, in this study, the dimensions are the 284 identified 
biochemicals. The principal components are unit-less and are ranked by how much 
variance they represent. Here, the first three principal components represent 72% of the 
total variance of the dataset, enough to be representative. PCA revealed a distinct 
separation of atg18 mutant animals from wild type and heterozygous atg18/wild type 
control animals, suggesting that they have significantly different metabolic signatures 
(Figure 3-2A).  To better visualize the metabolic differences, we generated a heatmap of 
our metabolomics data, and indeed saw a clear difference between atg18 mutants and the 
two controls (Figure 3-2B). Quantitative bioinformatic analyses revealed significant 
differences in glycogen metabolism, glycolysis, lipid metabolism, and amino acid 
metabolism. Inhibition of autophagy causes a decrease in protein catabolism and 
decreased free amino acids (Onodera and Ohsumi, 2005). As a simple validation for our 
study, we checked the relative abundance of amino acid metabolites in our samples. The 
majority of amino acid metabolites were decreased in atg18 mutants compared to 
controls (Figure 3-2C), suggesting that our metabolomics results are biologically 
relevant. 
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Figure 3-2 
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Figure 3-2. Metabolomics profiling of atg18 mutant animals is different from control 
animals at 24 hours apf. (A) PCA on the binned spectra shows that atg18 mutants are 
clearly separable from wild type and heterozygous atg18 controls along PC1. (B) 
Heatmap profile of all identified biochemicals. atg18 mutant (atg18KG03090/Df6112) animals 
(red columns), heterozygous atg18 control (atg18KG03090/+) animals (green columns), wild 
type (CantonS) animals (blue columns).  (C) Heatmap profile of amino acids and amino 
acid intermediates. atg18 mutant (atg18KG03090/Df6112) animals (red columns), 
heterozygous atg18 control (atg18KG03090/+) animals (green columns), wild type 
(CantonS) animals (blue columns). 
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atg18 mutants have increased lactate levels 
In mammalian cell culture, inhibiting autophagy during growth factor restriction 
causes a decrease in intracellular ATP levels, suggesting that autophagy is required for 
ATP production during stress (Lum et al., 2005). During Drosophila metamorphosis, the 
animal does not feed and therefore does not receive nutrients from environmental 
resources. Despite this lack of nutritional input, the animal is completely remodeled; 
larval tissues degrade and adult tissues grow, and these are both energy intensive 
processes. Autophagy may be required during metamorphosis to maintain ATP levels to 
provide energy for tissue remodeling. To test this, we measured ATP levels in control and 
atg18 mutant pupae at 24 hours apf. Surprisingly, we found that ATP levels in atg18 
mutants did not differ significantly from those in wild type animals and were only 
slightly lower than those in heterozygous atg18/wild type control animals (Figure 3-3A). 
This result contradicts previous studies in mammalian cell culture (Lum et al., 2005; Guo 
et al., 2011) and may reflect an intact organism’s ability to adapt to get the energy it 
needs to survive. 
A possible explanation for why ATP levels are unchanged in atg18 mutants is that 
the animals compensate by changing their behavior in some way. One way autophagy 
deficient larvae could change their behavior to prepare for metamorphosis is to increase 
their food intake and nutrient storage. We assayed food intake of feeding 3rd instar larvae 
and found that atg18 mutant larvae consumed a similar amount of media as the control 
larvae (Figure 3-3B), suggesting that food intake was unchanged in mutant larvae. In 
addition, we tested whether atg18 mutant larvae have increased nutrient storage by 
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measuring hemolymph trehalose levels in wandering 3rd instar larvae. We found that 
atg18 mutant larvae had similar levels of trehalose in hemolymph as control animals 
(Figure 3-3C). Taken together, these results suggest that atg18 mutants do not adjust their 
behavior to either consume or store more nutrients in preparation for metamorphosis. 
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Figure 3-3 
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Figure 3-3. atg18 mutation does not affect feeding behavior or energy storage. (A) 
ATP levels were measured in wild type animals (CantonS), heterozygous atg18 control 
(atg18KG03090/+) animals, and atg18 mutant (atg18KG03090/Df6112) animals, at 24 hours apf. 
Data are represented as means ± SEM; n= 6. (B) The amount of blue food dye consumed 
by feeding third instar larvae was measured in wild type animals (CantonS), 
heterozygous atg18 control (atg18KG03090/+) animals, and atg18 mutant 
(atg18KG03090/Df6112) animals. Data are represented as means ± SEM; n= 3. (C) 
Hemolymph trehalose levels were measured in wandering larvae of wild type animals 
(CantonS), heterozygous atg18 control (atg18KG03090/+) animals, and atg18 mutant 
(atg18KG03090/Df6112) animals. Data are represented as means ± SEM; n≥ 9. Statistical 
significance for all assays was determined using a Student’s t test. 
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Another explanation for the similar levels of ATP is that the atg18 mutant animals 
have a shift in their metabolism to alternative pathways for ATP production. We queried 
the autophagy mutant metabolomics data for changes in biochemicals involved in energy 
production. One metabolite that stood out was lactate. At 24 hours apf, lactate levels in 
atg18 mutants are approximately 2-fold higher than in control animals (Figure 3-4A). We 
verified this result by assaying for lactate in pupae and found that atg18 mutant animals 
did indeed have increased lactate levels at 24 hours apf (Figure 3-4B). Elevated lactate 
levels can be indicative of an increase in the rate of glycolysis. Another metabolic 
indicator of increased glycolytic rate is decreased glucose levels as glucose consumption 
is increased. Consistent with elevated glycolysis, atg18 mutant animals possess lower 
glucose levels than both controls (Figure 3-4C). Taken together, these results suggest that 
there is a shift to a more glycolytic metabolism in atg18 mutants. 
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Figure 3-4 
 
 
 
 
 
 
 
105 
 
Figure 3-4. Glycolysis is increased in atg18 mutants at 24 hours apf. (A) Scaled 
intensity of lactate levels from metabolomic analysis of wild type animals (CantonS), 
heterozygous atg18 control (atg18KG03090/+) animals, and atg18 mutant 
(atg18KG03090/Df6112) animals, at 24 hours apf. Statistical significance was determined 
using a Welch’s Two-Sample t-Test. (B) Lactate levels were measured in wild type 
animals (CantonS), heterozygous atg18 control (atg18KG03090/+) animals, and atg18 
mutant (atg18KG03090/Df6112) animals, at 24 hours apf. Data are represented as means ± 
SEM; n= 3. Statistical significance was determined using a Student’s t test. (C) Scaled 
intensity of glucose levels from metabolomic analysis of wild type animals (CantonS), 
heterozygous atg18 control (atg18KG03090/+) animals, and atg18 mutant 
(atg18KG03090/Df6112) animals, at 24 hours apf. Statistical significance was determined 
using a Welch’s Two-Sample t-Test. 
 
 
 
 
 
 
 
 
 
 
 
 
106 
 
Tissue-specific autophagy inhibition affects whole animal lactate levels 
Developmentally programmed autophagy is induced in several larval tissues 
during early metamorphosis, including the fat body, salivary glands, and midgut (Lee and 
Baehrecke, 2001; Lee et al., 2002a; Rusten et al., 2004; Berry and Baehrecke, 2007). We 
asked whether inhibiting autophagy in individual larval tissues could affect whole animal 
metabolism. Using lactate levels as a readout for metabolic change, we tested the effect 
of knocking down either atg1 or atg7 in the midgut, fat body, and salivary glands. NP1-
GAL4 driven expression of either atg1IR or atg7IR in the midgut caused an insignificant 
increase in organismal lactate levels (Figure 3-5A). Cg-GAL4 driven expression of 
atg7IR, but not atg1IR, in the fat body caused a significant increase in organismal lactate 
levels (Figure 3-5A). Finally, fkh-GAL4 driven expression of either atg1IR or atg7IR in the 
salivary glands caused increased organismal lactate levels (Figure 3-5A). These results 
indicate that autophagy in specific larval tissues affects whole animal metabolism. 
Growth arrest is required for developmentally regulated autophagy in Drosophila 
salivary gland cells (Berry and Baehrecke, 2007). Class I PI3K promotes cell growth and 
is an oncogene involved in many cancers. When the catalytic subunit of class I PI3K, 
Dp110, is mis-expressed in Drosophila salivary gland cells, growth arrest does not occur 
and autophagy is inhibited (Berry and Baehrecke, 2007). Since Dp110 negatively 
regulates autophagy, we asked whether mis-expression of this oncogene in specific 
tissues could affect organismal metabolism. We found that expression of Dp110 in either 
the midgut (NP1-GAL4) or the salivary glands (fkh-GAL4) caused a significant increase 
in whole animal lactate levels, while expression in the fat body (cg-GAL4) did not cause 
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a significant increase in lactate levels (Figure 3-5B). These results indicate that 
expression of Dp110 in larval tissues can alter whole animal metabolism. 
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Figure 3-5
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Figure 3-5. Tissue specific inhibition of autophagy affects organismal lactate levels. 
(A) Lactate levels were measured in control animals (+/w; UAS-atg1IR/+ and +/w; UAS-
atg7IR/+), those with salivary gland-specific knockdown of atg1 (fkh-GAL4/w; UAS-
atg1IR/+) and atg7 (fkh-GAL4/w; UAS-atg7IR/+), those with fat body-specific knockdown 
of atg1 (cg-GAL4/+; UAS-atg1IR/+) and atg7 (cg-GAL4/+; UAS-atg7IR/+), and those 
with midgut-specific knockdown of atg1 (NP1-GAL4/+; UAS-atg1IR/+) and atg7 (NP1-
GAL4/+; UAS-atg7IR/+) at 24 hours apf. Data are represented as means ± SEM, n= 3. 
Statistical significance was determined using a Student’s t test. (B) Lactate levels were 
measured in control animals (+/w; UAS-dp110/+), those with salivary gland-specific 
expression of dp110 (fkh-GAL4/w; dp110/+), those with fat body-specific expression of 
dp110 (cg-GAL4/+; UAS-dp110/+), and those with midgut-specific expression of dp110 
(NP1-GAL4/+; UAS-dp110/+) at 24 hours apf. Data are represented as means ± SEM, n= 
3. Statistical significance was determined using a Student’s t test. 
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Since Dp110 mis-expression in salivary glands causes a global change in lactate 
levels during a period of extensive developmental remodeling, we were curious whether 
there were any physical phenotypes in adult tissues associated with Dp110 mis-
expression in salivary glands. Mis-expression of Dp110 in larval salivary glands causes a 
degradation defect with persistant salivary gland material at 24hr apf, well after normal 
gland degradation is complete (Berry and Baehrecke, 2007). However, whether salivary 
gland material persists throughout metamorphosis and how a gland degradation defect 
might affect adult tissues has never been studied. First, we tested whether gland material 
can persist past 24 hour apf. When we analyzed animals by histology, we found that mis-
expression of Dp110 in salivary glands led to persistence of gland material at 24 hours 
and 48 hours apf (Figure 3-6A, C). We measured developing adult structures, and found 
that at 24 and 48 hours apf, the heads and thoraxes of animals with Dp110 expressed in 
the salivary glands were significantly smaller than control animals (Figure 3-6B, D). We 
found a similar trend when we measured the heads and thoraxes of eclosed adults (Figure 
3-6E, F). These results suggest that mis-expression of Dp110 in salivary glands prevents 
proper adult structure formation.  
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Figure 3-6 
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Figure 3-6. Driving cell growth in larval salivary glands causes decreased size in 
adult structures. (A) Control animals (+/w; UAS-Dp110/+), n= 6, and those with 
salivary gland-specific expression of Dp110 (fkh-GAL4/w; UAS-Dp110/+), n= 6, were 
analyzed by histology for head width and thorax length 24 hours apf. Scale bars represent 
100 microns. (B) Quantification of data from (A). Data are represented as means ± SEM. 
Statistical significance was determined using a Student’s t test. (C) Control animals (+/w; 
UAS-Dp110/+), n= 9, and those with salivary gland-specific expression of Dp110 (fkh-
GAL4/w; UAS-Dp110/+), n= 11, were analyzed by histology for head width and thorax 
length 48 hours apf. Scale bars represent 100 microns. (D) Quantification of data from 
(C). Data are represented as means ± SEM. Statistical significance was determined using 
a Student’s t test. (E) Adult control animals (+/w; UAS-Dp110/+), n= 12, and those with 
salivary gland-specific expression of Dp110 (fkh-GAL4/w; UAS-Dp110/+), n= 12, were 
analyzed by microscopy for head width and thorax length. Scale bars represent 100 
microns. (F) Quantification of data from (E). Data are represented as means ± SEM. 
Statistical significance was determined using a Student’s t test. 
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Discussion 
Although autophagy is an important catabolic process that is often deregulated in 
human disease, few studies have taken an unbiased metabolomics approach to determine 
how autophagy deficiency affects metabolism in animals. In this study, we investigated 
the contribution of autophagy to organismal metabolism during metamorphosis in 
Drosophila. We demonstrated that defects in autophagy lead to a global shift in 
metabolism, characterized by reduced amino acid levels, decreased nucleotide 
intermediates, reduced pentose phosphate pathway intermediates, decreased -oxidation, 
and increased glycolysis. Additionally, inhibition of autophagy in larval tissues affects 
global metabolism and may impact adult tissue formation through bioenergetics resource 
management. 
Previous studies in cell culture have identified some metabolic changes caused by 
autophagy deficiency. In atg5-/- mouse embryonic fibroblasts (MEFs), metabolic 
profiling revealed a decrease in nonessential amino acids, altered lipid metabolism, 
increased nucleotide intermediates, and unchanged glycolysis (Lin et al., 2012). Our 
results show some similarities, including decreased amino acids and altered lipid 
metabolism, and some differences, decreased nucleotide intermediates and increased 
glycolysis. These differences may reflect the different systems used, cell culture versus 
whole animal. Specifically, the similar changes in metabolites may reflect the cell 
autonomous influence of autophagy on metabolism, whereas the differences could reflect 
the cell non-autonomous influence of autophagy on other cells and tissues. Another factor 
that could cause these differences is the nutritional status of cells and the animal.  Guo et 
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al., (2013) analyzed the metabolic profiles of atg7+/+ and atg7-/- tumor derived cell 
lines, and saw an increase in glycolytic intermediates when they starved the atg7-/- cells, 
but not when the cells were in nutrient rich conditions. This increase in glycolysis is 
similar to our observation in autophagy mutant animals. Although pupae are not 
specifically starved, they are in a non-feeding state and could respond metabolically as 
though in a state of starvation. As neither us nor Guo et al., (2013) observed much 
change in ATP levels, the increase in glycolysis is likely responsible for maintaining ATP 
levels in autophagy deficient cells.  
Autophagy plays paradoxical roles in tumorigenesis. Autophagy can either 
suppress or promote tumorigenesis depending on the context. One interesting theory that 
explains this behavior is the ‘autophagic tumor stroma model’. According to this model, 
the catabolic process of autophagy in the tumor stromal cells produces recycled nutrients 
which then drive anabolic growth in the tumor cells creating an energy imbalance 
(Martinez-Outschoorn et al., 2010b). Therefore, inhibiting autophagy in tumor stromal 
cells would starve the tumor cells and limit tumor cell growth. We observed a similar 
effect when we mis-expressed Dp110 in the larval salivary glands. Driving growth and 
inhibiting autophagy in salivary glands lead to less growth of the surrounding adult 
tissues suggesting that there is a re-allocation of nutrients from larval tissues to adult 
tissues during metamorphosis. This natural re-allocation of nutrients during 
metamorphosis provides a useful model for studying in vivo how autophagy in one cell 
type can affect the metabolism of another.  
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It is interesting that inhibiting autophagy in a single tissue can affect lactate levels 
on an organismal level. This suggests that the autophagy in degrading tissues is important 
to the animal’s metabolic homeostasis. An interesting question that remains is where is 
the increased lactate coming from, degrading larval tissues or growing adult tissues? 
 
Material and Methods 
Drosophila strains 
We used the following fly stocks: Canton-S as wild-type control. For loss of function 
mutations, we used atg18KG03090 and Df(3L)6112 (Bloomington Stock Center). For RNAi 
knockdown assays, we used UAS-atg1IR TID 16133 and UAS-atg7IR TID 45561 (VDRC). 
For mis-expression studies, I used UAS-p35 and UAS-Dp110. 
ATP Assay 
The ATP Bioluminescence Assay Kit HSII (Roche) was used according to 
manufacturer’s instructions. Wild-type, atg18KG03090/+ control, and atg18KG03090/Df6112 
mutant white prepupae were collected and incubated at 25°C for 24 hours. 24-hour pupae 
were lysed in lysis buffer, 3 pupae/200l buffer. Lysates were centrifuged at 10,000 rpm 
for 5 minutes. Supernatants were collected and diluted 1:20 in dilution buffer. Samples 
were placed in 96 well white-wall plates and luciferase reagent was added. Luminescence 
was detected with a Beckman Coulter DTX 880.    
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Lactate Assay 
The Lactate assay kit (BioVision #K607-100) was used according to manufacturer’s 
instructions. White prepupae were collected and incubated at 25°C for 24 hours. Pupae 
were lysed in lactate assay buffer, 3 pupae/ 100l buffer. Lysates were centrifuged at 
10,000rpm for 5 minutes and supernatants were collected. Samples were placed in 96 
well plates, reaction mix was added, and incubated at room temperature in the dark. 
Flourescence was measured at Ex/Em= 535/590 nm with a Beckman Coulter DTX 880.  
Feeding Assay 
Feeding assay was adapted from (Edgecomb et al., 1994). Feeding 3rd instar larvae were 
collected and transferred to 10mm plates containing plain media (15% sucrose, 1% agar, 
water) or blue media (15% sucrose, 1% agar, 1% FD&C blue No. 1 food dye, water). 
Larvae were fed on media for 2 hours at 25°C. Midguts were dissected from larvae and 
homogenized in 75l PBS/10 guts. Samples were centrifuged at 14,000 rpm for 5 
minutes, the supernatant was collected, and absorbance measured at 620nm. 
Hemolymph Trehalose Assay 
Hemolymph trehalose was measured as described previously (Rulifson et al., 2002). 
Briefly, wandering larvae were washed with distilled water and blotted dry. Larvae were 
dissected, hemolymph was pipetted and quickly transferred into PCR tubes kept on ice. 
2L of hemolymph was added to 13L distilled water in a 1.5ml microcentrifuge tube. 
5L of trehalase from porcine kidney (Sigma, #T8778-1UN) was added to samples, and 
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samples were incubated at 37°C for 2 hours. Samples were put on ice to stop the enzyme 
reaction, then 130L of glucose assay reagent (Sigma, #GAHK20) was added to each 
sample. Samples were incubated at room temperature for 15 minutes. 100L of each 
sample was added to a 96 well plate and absorbance was measured at 340nm with a 
Beckman Coulter DTX 880. 
Histology 
Staged animals were placed in a dissection dish containing PBS, and their posterior end 
was cut using dissecting scissors exposing the inside of the animal. The pupae were fixed 
in 1 ml of 80% ethanol, 4% formaldehyde, 5% acetic acid, 1% glutaraldehyde (FAAG) in 
a 1.5 ml centrifuge tube overnight at 4°C. Pupae were dehydrated by removing FAAG, 
then incubated at room temperature with 1 ml of 80% ethanol for 10min, 85% ethanol for 
15min, 90% ethanol for 20min, 100% ethanol for 25min, 100% ethanol for 75min, 
xylenes for 25min, and xylenes for 75min. Pupae were transferred using a paint brush to 
a scintillation vial containing approximately 20 paraplast x-tra chips (McCormick 
Scientific 39503002) and 2 ml xylenes. The scintillation vial was incubated overnight at 
45°C. The wax/xylenes solution was decanted, melted paraplast x-tra was added to vials, 
and samples were incubated at 55°C. Wax changes were repeated two more times over 1 
day. Pupae and wax were poured into paper boats used for paraffin histology, pupae were 
oriented ventral side down using toothpicks, and wax was allowed to solidify overnight. 
Square blocks were cut around each pupa leaving approximately 0.5cm of space around 
the pupa. Blocks with embedded pupa were sectioned using a microtome set to 7m. 
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Ribbons of sections were floated on water on a microscope slide on a slide warmer set to 
45°C. When the sectioning was complete, the water was removed with a paper towel, and 
the slides were incubated overnight on the slide warmer. Slides were placed in a staining 
rack and hydrated, stained, and dehydrated in staining dishes using the following series: 
first xylenes for 3min, second xylenes for 3min, first 100% ethanol for 3min, second 
100% ethanol for 3min, 90% ethanol for 3min, 70% ethanol for 3min, running tap water 
for 5min, Weigert’s Hematoxylin for 5min, running tap water for 5min, Pollak trichrome 
for 7min, distilled water for 10sec, 0.2% glacial acetic acid in distilled water for 10sec, 
70% ethanol for 3min, 90% ethanol for 3min, second 100% ethanol for 3min, first 100% 
ethanol for 3min, second xylenes for 3min, and first xylenes for 3min. Slides were dried 
and cover slips were mounted with approximately 1 l Permount for each mm2 of cover 
slip area. 
Global Metabolic Profiling 
White prepupae of appropriate genotypes were collected, incubated at 25°C for 24 hours 
and then stored at -80°C. I collected 100 pupae per sample, and there were six samples 
per genotype. The sample preparation process was carried out using the automated 
MicroLab STAR® system from Hamilton Company.  Recovery standards were added 
prior to the first step in the extraction process for QC purposes.  Sample preparation was 
conducted using Metabolon’s proprietary series of organic and aqueous extractions to 
remove the protein fraction while allowing maximum recovery of small molecules 
(http://www.metabolon.com/).  The resulting extract was divided into two fractions; one 
for analysis by liquid chromatography (LC) and one for analysis by gas chromatography 
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(GC).  Samples were placed briefly on a TurboVap® (Zymark) to remove the organic 
solvent.  Each sample was then frozen and dried under vacuum.  Samples were then 
prepared for the appropriate instrument, either LC/MS or GC/MS. The LC/MS portion of 
the platform was based on a Waters ACQUITY UPLC and a Thermo-Finnigan LTQ mass 
spectrometer, which consisted of an electrospray ionization (ESI) source and linear ion-
trap (LIT) mass analyzer.  The sample extract was split into two aliquots, dried, then 
reconstituted in either acidic or basic LC-compatible solvents, each of which contained 
11 or more injection standards at fixed concentrations.  One aliquot was analyzed using 
acidic positive ion optimized conditions and the other using basic negative ion optimized 
conditions in two independent injections using separate dedicated columns.  Extracts 
reconstituted in acidic conditions were gradient eluted using water and methanol both 
containing 0.1% Formic acid, while the basic extracts, which also used water/methanol, 
contained 6.5mM Ammonium Bicarbonate.  The MS analysis alternated between MS and 
data-dependent MS2 scans using dynamic exclusion. The samples destined for GC/MS 
analysis were re-dried under vacuum desiccation for a minimum of 24 hours prior to 
being derivatized under dried nitrogen using bistrimethyl-silyl-triflouroacetamide 
(BSTFA).  The GC column was 5% phenyl and the temperature ramp is from 40° to 300° 
C in a 16 minute period.  Samples were analyzed on a Thermo-Finnigan Trace DSQ fast-
scanning single-quadrupole mass spectrometer using electron impact ionization.  The 
instrument was tuned and calibrated for mass resolution and mass accuracy on a daily 
basis. For data analysis, any missing values were imputed with the minimum observed 
value for each compound, values were normalized to Bradford protein concentration of 
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the sample, normalized values were scaled to the median, then values were log 
transformed. Welch’s two-sample t-test was used to identify biochemicals that differed 
significantly between experimental groups. 
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Chapter IV 
Discussion 
The role of Ral and the exocyst in salivary gland degradation 
Ral and the exocyst have been implicated in the regulation of autophagy in 
response to amino acid starvation and pathogen stress in derived mammalian cell lines 
(Bodemann et al., 2011). I sought to determine whether Ral and the exocyst are broad 
regulators of autophagy in vivo by investigating whether they are involved in two 
physiological models of autophagy in the Drosophila; autophagic cell death of the larval 
salivary glands and starvation induced autophagy in the larval fat body. I provide the first 
in vivo evidence that Ral and the exocyst regulate autophagy associated with cell death. 
Surprisingly, neither Ral nor the exocyst were required for starvation induced autophagy 
in the larval fat body. This result contradicts previous studies in mammalian cell lines and 
suggests that Ral and the exocyst regulate autophagy in a context-specific manner. 
However, several important questions still need to be addressed regarding the role of Ral 
and the exocyst in autophagy. 
My data in Chapter II suggest that ral is required for salivary gland degradation as 
knockdown of ral, ral mutation, expression of a dominant negative ral, and knockdown 
of rgl all cause a persistent salivary gland phenotype by histology (Figure 2-1). The ral 
mutant has a less severe phenotype than the knockdowns and the dominant negative. This 
could be due to the hypomorphic nature of the allele and the mutant could have more Ral 
protein expression or activity than the knockdowns or dominant negative. However, 
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animals with ubiquitous ral knockdown and the ral mutant have similar Ral protein 
levels (Figure 2-2). One explanation for this could be that since ral is an essential gene, 
the animals with ubiquitous knockdown of ral that survive to the white pre-pupal stage 
represent animals with lower levels of ral knockdown. An important experiment that 
needs to be done is to measure the Ral protein levels in salivary glands from ral mutants 
and animals with gland specific knockdown of ral. An additional reason that the ral 
mutant could have a weaker phenotype is that it has maintained more Ral activity than 
the knockdowns or dominant negative. Ideally, I would test this possibility by doing a Ral 
activation assay. However, this assay relies on the co-immunoprecipitation (coIP) of 
activated Ral with a Ral-binding domain, and there may not be enough material from 
salivary glands alone for coIP. If it were possible to do this assay using salivary glands, 
then I would also use it to test Ral activity during a time course of salivary gland 
degradation to determine if and when Ral is activated.  
My conclusion that Ral regulates salivary gland degradation through autophagy 
and not through caspase activity is supported by histological analysis, 
immunofluorescence, and Atg8 puncta formation analysis (Figures 2-4, 2-5, 2-6). There 
are several experiments that I would do to strengthen this conclusion. One issue with the 
ral and p35 epistasis experiment is that scoring the histology for cell fragments versus 
gland fragments can be somewhat subjective. To account for this, I had the histology for 
this experiment scored blindly by other members of the lab. To further strengthen the 
conclusion that Ral does not affect caspases during salivary gland degradation, I would 
do immunofluorescence staining for nuclear lamin, a caspase substrate, in ral knockdown 
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salivary glands and salivary glands from ral mutants. If Ral does not affect caspase 
activity, then I would expect to see reduced nuclear lamin staining at 14hr apf compared 
to 6hr apf. One weakness of the data supporting the conclusion that Ral regulates 
autophagy is the epistasis experiment with the ral mutant and atg6 knockdown (Figure 2-
5) as the mutant is a hypomorph and the atg6 knockdown gives a relatively weak 
phenotype. Ideally, epistasis experiments are done with null mutants. However, this is not 
possible for my studies as ral and most atg genes are essential, and null mutants are 
lethal. To strengthen this data, I would perform additional epistasis experiments using 
knockdown of a variety of atg genes in the ral mutant background as well as knockdown 
of ral in the atg18 mutant background. Finally, the result that atg1 mis-expression in 
salivary glands of ral mutants rescues the mutant’s gland degradation defect (Figure 2-6) 
suggests that atg1 is downstream of ral. The issue with this data is that the atg1 mis-
expression in the ral mutant background caused developmental defects not normally 
observed when atg1 is mis-expressed. This could be due to some non-specific genetic 
interaction. To test this, I would mis-express a different atg1 allele in the ral mutant 
background and assay for rescue of the salivary gland degradation defect by histology. 
While there is strong evidence for ral being required for autophagy, it is remains 
unclear whether active ral is sufficient to induce autophagy. Bodemann et al showed that 
expression of constitutively active RalB in HBEC3-KT cells caused LC3 puncta 
accumulation during fed conditions (Bodemann et al., 2011). In contrast, Martin et al 
showed that constitutively active RalB expressed in HEK293T cells associates with 
mTOR and causes increased levels of pS6K, suggesting that active RalB promotes 
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mTOR activity (Martin et al., 2014). Presumably, this would inhibit autophagy as mTOR 
is a negative regulator of autophagy, however, Martin et al did not test the effect of 
constitutively active Ral on autophagy. I tested whether ral was sufficient to induce 
premature salivary gland degradation, and found that it was not (Figure 2-3). Although 
this is not direct evidence, it does suggest that ral may not be sufficient for autophagy 
induction in salivary glands. To be more conclusive, I would need to assay for premature 
mCherryAtg8 puncta formation in salivary glands expressing constitutive active ral. 
Interestingly, the salivary glands with expression of constitutively active ral appear to 
have morphological defects and to be less organized. This could be caused by another 
function of Ral. In mammalian cells, Ral is involved in the regulation of tight junctions 
(Hazelett et al., 2011), and Drosophila have a tight junctions analog, septate junctions. 
Constitutively active ral expression in the salivary glands could be disrupting septate 
junction formation. This could be easily tested by staining for a septate junction marker 
such as coracle.  
 It remains unknown how Ral fits into the regulation of autophagy in degrading 
salivary glands. There are several upstream activators of Ral, including Ras and Rap 
signaling through Ral-GEFs and Ca2+/calmodulin binding (Hofer et al., 1994, 1998; 
Kikuchi et al., 1994; Wolthuis et al., 1998; Wang and Roufogalis, 1999; Mirey et al., 
2003). Microarray data from our lab indicate that rgl and roughened, the Rap1 
orthologue, RNA levels increase in salivary glands 2.5 fold and 9.7 fold, respectively, 
between 6h and 14h apf (unpublished). Given that my results in chapter II indicate that 
Rgl is required for salivary gland cell death, I would next test whether Rgl is required for 
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autophagy in salivary glands, then I would test whether roughened is required for salivary 
gland degradation and autophagy in salivary glands. To strengthen the conclusion that 
Rgl is required for salivary gland degradation, I would do histology using rgl mutants at 
24hr apf to check for a salivary gland degradation defect. Next, I would test whether Rgl 
functions in the same pathway as autophagy by expressing RNAi targeting different atg 
genes specifically in salivary glands of an rgl mutant background and checking for 
phenotype enhancement by histology.  I would also test whether Rgl is required for 
autophagy in salivary glands by assaying for mCherryAtg8 puncta formation during 
salivary gland degradation in mosaic rgl mutant animals. I would perform similar 
experiments to test the requirement of roughened during salivary gland degradation. I 
would express RNAi targeting roughened specifically in salivary glands and assay for 
gland clearance at 24hr apf by histology. I would also test roughened mutants for gland 
degradation defects at 24hr apf by histology. If there is a gland degradation defect, then I 
would do the epistasis experiments with knockdown of atg genes by histology and also 
assay for mCherryAtg8 puncta formation during salivary gland degradation in mosaic 
roughened mutant animals. 
 Alternatively, Ral could be activated by calcium-dependent binding of calmodulin 
to regulate autophagy in degrading salivary glands. Recently, it has been shown that 
preceding salivary gland cell death, there is a release of calcium mediated by miR-14 
regulation of ip3k2 (Nelson et al., 2014). Additionally, Nelson et al demonstrated that 
calmodulin is required for autophagy during salivary gland cell death, but is dispensable 
for starvation induced autophagy in the fat body. To test the hypothesis that Ral is 
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activated by calcium-dependent calmodulin binding, I would test salivary gland lysates 
for coIP of calmodulin and Ral. However, due to the small size of this tissue, there may 
not be sufficient material to detect coIP of calmodulin and Ral. In which case, I would 
also test the genetic interactions of Ral with calmodulin and ip3k2. To do this, I would 
knockdown both calmodulin and ral in salivary glands and check for phenotype 
enhancement by histology. If they function in the same pathway, there should be no 
enhancement of their gland degradation defects. Knockdown of ip3k2 in salivary glands 
induces early mCherryAtg8 puncta formation (Nelson et al., 2014). To check whether ral 
functions downstream of ip3k2, I would knockdown ral and ip3k2 in salivary glands and 
assay for mCherryAtg8 puncta formation. If ral functions downstream of ip3k2, then 
knockdown of ral should block the early mCherryAtg8 puncta formation caused by ip3k2 
knockdown. 
 The current model for how Ral and the exocyst regulate autophagy is that active 
RalB utilizes two distinct exocyst subcomplexes. During growth factor stimulation, RalB 
interacts with Sec5 to promote mTOR activity and inhibit autophagy, and during nutrient 
restriction, RalB interacts with Exo84 to promote ULK1/Atg1 activation (Bodemann et 
al., 2011; Martin et al., 2014). In the Bodemann et al study, Sec8, Sec3 and Exo70 in 
addition to Exo84 are required for amino acid starvation induced autophagy, whereas 
depletion of the remaining subunits, Sec6, Sec10, and Sec15 caused increased autophagy 
during amino acid starvation suggesting that they inhibit autophagy (Bodemann et al., 
2011). My results indicate that Sec5, Sec15, Sec8, Sec3, and Exo84 are all required for 
autophagy in salivary glands, contradicting the current model of how Ral and the exocyst 
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regulate autophagy. I also tested knockdown of Sec6 and Exo70, however, neither had 
any phenotypes (data not shown). This could be due to insufficient knockdown by the 
RNAi’s. Interestingly, a recent study provides further evidence contradicting the 
prevailing two exocyst subcomplex model of regulation. It was shown that Sec5 was 
required for basal autophagy and serum starvation-induced autophagy in MDA-MB-231 
cells, while Sec6, Sec8, and Exo70 were all required for basal autophagic turnover (Tan 
et al., 2015). Given that each of these studies investigates different modes of autophagy 
induction and uses different cell types, it is possible that the exocyst subunits function 
differently depending on cell type and context. Future studies in different cell types and 
contexts should address this issue. 
 Since my results contradict the current model for how the exocyst regulates 
autophagy, it is important to test the entire model of how Ral regulates autophagy. mTOR 
is a known negative regulator of autophagy, and it has been shown to regulate salivary 
gland degradation (Berry and Baehrecke, 2007). There is evidence in mammalian cells 
that both RalA and RalB can activate mTORC1, however this is accomplished through 
distinct upstream stimuli. RalA is required for nutrient-induced activation of mTORC1 
(Maehama et al., 2008; Xu et al., 2011) and RalB is required for mTORC1 activation 
induced by growth factor stimulation (Martin et al., 2014). It remains unknown whether 
Ral is upstream of TOR in the context of cell death associated autophagy. It is important 
to do the genetic epistasis experiments to determine whether Ral functions upstream of 
TOR or independently of TOR in the context of salivary gland degradation. To do this, I 
would express dominant negative TOR specifically in the salivary glands of the ral 
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mutant and assay for salivary gland degradation defect by histology. If TOR is 
downstream of Ral, then expressing dominant negative TOR in a ral mutant background 
should rescue the ral mutant salivary gland degradation defect. 
 The Ral/exocyst effector complex is an important spatiotemporal regulator of 
several membrane trafficking processes. My findings indicate that Ral and the exocyst 
are necessary for both developmentally programmed protein secretion and autophagy in 
larval salivary glands. These two processes occur in a specific order with protein 
secretion being triggered by one ecdysone pulse, and autophagy being triggered by a later 
ecdysone pulse (Biyasheva et al., 2001; Lee and Baehrecke, 2001). One intriguing 
possibility is that protein secretion must occur before autophagy can initiate, and 
disruption of the Ral/exocyst effector complex affects the temporal regulation of these 
two processes. I have tried to test this hypothesis by using the temporal and regional gene 
expression targeting (TARGET) system (McGuire et al., 2003) of a temperature sensitive 
GAL80 allele to repress UAS-ralIR expression during development until glue secretion 
occurs, then switching to the restrictive temperature to allow fkh-GAL4 driven expression 
of UAS-ralIR. Unfortunately, this system did not seem to work, and controls using the 
expression of UAS-GFP suggest that the amount of time between glue secretion and 
initiation of salivary gland degradation is insufficient for GAL4 driven expression to be 
induced. An alternative approach would be to use a drug-inducible GAL4 (Roman and 
Davis, 2002) to temporally regulate Ral expression, however, the requirement of feeding 
or injecting the animals with the appropriate ligand is a major disadvantage of this 
technique, and it may have a similar timing issue as the TARGET system. Ideally, a 
131 
 
temperature-sensitive Ral mutant would be used to test the temporal regulation of glue 
secretion and autophagy, but currently no such allele exists. However, there is a 
temperature sensitive sec5 allele, and this could be used to test whether the exocyst is 
required for temporal control of these processes. 
 
The role of Ral and the exocyst in starvation-induced autophagy 
In chapter II, I provided evidence that Ral and the exocyst are dispensable for 
starvation induced autophagy in the larval fat body. This was surprising since previous 
studies in mammalian cells have implicated Ral and the exocyst in the regulation of 
starvation induced autophagy (Bodemann et al., 2011). However, as I have discussed 
previously, how Ral and the exocyst regulate autophagy appears to depend on cell 
context. One possibility as to why expressing RNAis targeting ral and the exocyst 
subunits had no effect on starvation-induced autophagy could be that their knockdown is 
inefficient in the fat body. An important experiment that needs to be done is to analyze 
ral and exocyst subunit expression levels by real time qRT-PCR in fat bodies expressing 
their targeting RNAis. To further strengthen the conclusion that Ral and the exocyst are 
dispensable for starvation induced autophagy in the larval fat body, I would also assay for 
mCherryAtg8 puncta formation in starved fat bodies of mosaic ral and exocyst mutants.    
Why Ral and the exocyst would regulate autophagy in the salivary gland but not 
the fat body remains unclear. One possibility is that Ral is not expressed in the fat body. I 
checked Ral protein expression in fat bodies from feeding and starved larvae, and found 
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that Ral is expressed in the fat body (Figure 4-1A). Surprisingly, Ral expression is 
increased during starvation suggesting that Ral probably plays some role in the fat body 
during starvation. Ral is involved in multiple membrane trafficking processes and in the 
fat body it might be required for another process other than autophagy. I explored this 
possibility by performing EM on starved fat bodies from control larvae and larvae with 
fat body specific expression of dominant negative Ral (Figure 4-1B). I found that 
amphisomes/autolysosomes (electron dense, single-membrane vesicles) are present in 
control and dominant negative Ral-expressing fat bodies, however, in fat bodies 
expressing the dominant negative Ral, I also saw fewer large lipid droplets. It has been 
shown that during starvation, lipid droplets aggregate (Zhang et al., 2000; Colombani et 
al., 2003; Gutierrez et al., 2007). Intriguingly, there is in vitro evidence that RalA and 
RalB are enriched in the lipid droplet fraction of mammalian cells (Liu et al., 2004). It is 
possible that Ral regulates the process of lipid droplet fusion. Given that lipid droplets 
play an important role in several human metabolic diseases (Greenberg et al., 2011), 
future studies should investigate this novel potential role for Ral in the regulation of lipid 
droplet homeostasis. 
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Figure 4-1 
 
Figure 4-1. Ral and the fat body. (A) Protein extracts from wild type Canton-S fat 
bodies of fed and starved third instar larvae were analyzed by western blotting with an 
anti-hRalB antibody. (B) TEM of fat bodies from starved control (+/+; UAS-ralDN/+) 
third instar larva and starved third instar larva with fat body-specific expression of ralDN 
(cg-GAL4/+; UAS-ralDN/+). Lipid droplets (red stars) and amphisomes/autolysosomes 
(black box) are highlighted. 
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In Chapter II, I provided data in support of Ral and the exocyst regulating 
autophagy in a tissue-specific manner in vivo. I found that Ral and the exocyst are 
required for cell death associated autophagy in salivary glands, and in contrast to 
previous studies, are dispensable for starvation-induced autophagy. There are two 
significant differences between my study and the Bodemann study. First, I examined 
Ral/exocyst regulation of autophagy in response to physiological induction of autophagy 
in vivo, whereas Bodemann et al studied Ral/exocyst regulation of autophagy in derived 
cell lines in response to artificial induction of autophagy. Second, since my study was 
done in the fly, there was only one Ral ortholog as opposed to the two found in 
mammalian cells. This makes analysis of the pathway simpler because you do not have to 
account for redundant functions or opposing functions of the second ortholog. Human 
RalA and RalB are highly homologous, and their most significant sequence divergence is 
in their C-terminal membrane targeting sequences (Figure 1-3). This difference in 
sequences is responsible for RalA and RalB having distinct subcellular localization and 
contributes to their functional differences (Shipitsin and Feig, 2004; Martin et al., 2012; 
Neel et al., 2012). Drosophila Ral shares 72% sequence identity with RalA and 71% 
identity with RalB, and as with RalA and RalB, most of its sequence divergence occurs in 
the C-terminal membrane targeting sequence (Figure 1-3). This could mean that 
Drosophila Ral has distinct subcellular localization from both human RalB, and could 
account for these orthologs regulating autophagy in different contexts. This could be 
tested by immunofluorescence staining of endogenous Ral in salivary glands and fat body 
to determine Ral’s subcellular localization during autophagy in these tissues. In addition, 
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swapping the C-terminal sequences of Drosophila Ral and human RalB could alter Ral’s 
localization in fat body, and could potentially make it function in starvation-induced 
autophagy in the fat body. 
Although my data indicate a requirement of Ral and the exocyst in cell death 
associated autophagy, how Ral and the exocyst regulate autophagy in the salivary glands 
still remains unclear. Based on biochemical studies, it has been proposed that active RalB 
stimulates Exo84 to serve as a scaffold for the assembly of the Atg1 and Atg6 complexes 
which are required for autophagy, and that Sec5 and Exo84 have opposing roles in the 
regulation of autophagy (Bodemann et al., 2011). In contradiction to this model, I found 
that both Sec5 and Exo84 were required for autophagy in salivary glands. As discussed in 
Chapter I, Ral is thought to be important for assembly of the exocyst holocomplex, and 
the exocyst is thought to facilitate tethering of a vesicle to a target membrane. 
Additionally, autophagosome formation requires delivery of membranes from various 
sources. Therefore, I propose a model in which Ral is activated upstream by an unknown 
factor, active Ral binds either Sec5 or Exo84, triggering assembly of the exocyst, and the 
Ral/exocyst complex functions to target and tether vesicles to the nascent isolation 
membrane to aid in elongation and formation of the autophagosome.    
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Autophagy and metabolism 
Autophagy is a catabolic process that has a well established role in cell survival 
during stress. However, there is increasing evidence that autophagy is required for 
programmed cell death in various cell contexts (Lee and Baehrecke, 2001; Lee et al., 
2002a; Berry and Baehrecke, 2007). Despite increasing interest in the study of autophagic 
cell death, it remains unclear why cells die with autophagy. An interesting hypothesis is 
that in multicellular organisms, autophagy in dying cells contributes non-cell 
autonomously to metabolism. I sought to determine whether autophagy in degrading 
tissues could contribute non-cell autonomously to organismal metabolism. To my 
knowledge, this is the first study to investigate the effect of autophagy deficiency on 
global metabolism in an intact animal.  
 I first took a global discovery approach to determine how autophagy contributes 
to metabolism during Drosophila development. Global metabolic profiling revealed that 
autophagy deficient animals have a global shift in their metabolism, characterized by 
reduced amino acid levels, decreased nucleotide intermediates, reduced pentose 
phosphate pathway intermediates, accumulation of long chain fatty acids, and increased 
glycolysis. While it is obvious from these results that disrupting autophagy causes major 
metabolic changes, it is unclear whether these pathways are just being affected at the 
level of substrate availability or if there are also transcriptional changes to key metabolic 
enzymes. To address this question it would be interesting to do a microarray and integrate 
those results with the metabolomics; this should provide a clearer picture of the changes 
that are occurring. In this study, I only profiled one atg mutant. To establish a more 
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complete signature of how autophagy affects metabolism during Drosophila 
development, it would be useful to profile additional mutants and look for commonalities. 
 Surprisingly, TCA cycle intermediates are relatively unaffected by autophagy 
deficiency in atg18-/- mutants. This result along with the stable ATP levels that I 
observed suggest that mitochondrial function is normal in this mutant. This contradicts 
several lines of evidence indicating that autophagy deficiency causes accumulation of 
damaged mitochondria in mammalian cells (Komatsu et al., 2005; Guo et al., 2011). Our 
lab has demonstrated that atg18-/- mutants accumulate mitochondria (Chang et al., 2013), 
however, the functionality of these mitochondria remains untested. Due to the 
contradictory nature of my results, it is important to test mitochondrial function in atg18-/- 
mutants. This will be done by measuring the oxygen consumption of control and atg18-/- 
mutant pupae. Based on my results that TCA cycle intermediates and ATP levels are 
relatively unaffected, I would expect atg18-/- mutants to have either normal or only 
slightly decreased oxygen consumption. 
 Alternatively, increased glycolysis could account for the stable ATP levels. 
Quiescent cells under aerobic conditions obtain the majority of ATP from oxidative 
phosphorylation, and under anaerobic conditions, they switch to a more glycolytic 
metabolism for ATP production. In contrast, cancer cells have a highly glycolytic 
metabolic program even under aerobic conditions. This phenomenon, termed aerobic 
glycolysis, was first described by Otto Warburg during the 1920s. Aerobic glycolysis is a 
common feature of cancer cells and non-transformed proliferative cells (Warburg, 1956; 
Hedeskov, 1968; Wang et al., 1976); it is characterized by increased glucose uptake and 
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lactate production. According to my results in Chapter III, atg18-/- mutants have elevated 
lactate levels and decreased glucose levels, suggestive of increased glucose utilization. 
These results are reminiscent of what is observed in cancer cells and indicate that in the 
absence of autophagy, pupae switch to a more glycolytic metabolism. As autophagy is 
believed to provide substrates for the TCA cycle to generate ATP, autophagy deficiency 
may cause animals to switch to a more glycolytic metabolism to maintain ATP levels and 
prolong survival. To test this, I would knock down key glycolytic enzymes in atg18-/- 
mutant animals, then measure their ATP levels and survival. 
An alternative hypothesis for the elevated glycolysis in autophagy deficient pupae 
is that glycolysis is supplying biomass, normally supplied by autophagy, for growing 
adult tissues. Although glycolysis does produce ATP, it is not as efficient as oxidative 
phosphorylation, yielding less ATP per glucose molecule than oxidative phosphorylation. 
Several of the glycolytic intermediates serve as precursors for the biosynthesis of 
nucleotides, amino acids, and fatty acids. Recently, it has been proposed that in addition 
to being an alternative pathway for ATP production, aerobic glycolysis contributes to the 
accumulation of biomass required for cell growth and proliferation (Vander Heiden et al., 
2009). It is possible that in autophagy deficient animals, glycolysis is increased to 
provide precursors for the biomolecules required for cell growth. I found that inhibiting 
autophagy in specific larval tissues lead to increased lactate levels. Unfortunately, the 
source of this lactate remains unknown. An important next step is to identify whether the 
lactate is being produced by the larval tissues or the adult tissues. I would attempt this by 
performing lactate assays on dissected tissues, however, this approach may be limited by 
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technical issues. An alternative approach would be to use a genetically encoded lactate 
biosensor to monitor lactate levels in specific tissues (San Martín et al., 2013). This 
method is untested in flies and may not be viable until the technology has developed 
further.  
As I previously mentioned, I found that inhibiting autophagy in specific larval 
tissues caused increased lactate levels. This was done by knocking down either atg1 or 
atg7, two core autophagy genes. Further testing with knockdown of additional core atg 
genes would improve the conclusiveness of my results. In addition to testing additional 
atg genes, I would also test the knockdown of these genes in each tissue by real time 
qRT-PCR. In my results, atg7 and atg1 knockdown in the fat body had different effects 
on lactate levels (Figure 3-5). This could be a consequence of differences in knockdown 
efficiency of these genes in the fat body; measuring the knockdown by real time qRT-
PCR would address this possibility. 
In addition to tissue-specific autophagy inhibition affecting global lactate levels, it 
is likely that tissue-specific autophagy inhibition has more global metabolic 
consequences. An interesting question to pursue would be which metabolic pathways are 
altered in which tissues. To address this question, I would first use a discovery approach. 
Recently, metabolic profiling has been done on individual tissues in Drosophila 
melanogaster (Chintapalli et al., 2013). I would use this approach to determine how 
inhibiting autophagy in one tissue affects the metabolic profiles of several individual 
tissues. Next, I would take a more targeted approach and measure the tissue levels of 
specific biochemicals that were discovered in the metabolic profiling. 
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My results in Chapter III on Dp110 mis-expression in salivary glands affecting 
surrounding tissue growth (Figure 3-6) suggest that there is a re-allocation of nutrients 
from larval tissues to adult tissues. One confounding factor is that Dp110 not only 
inhibits autophagy, but also promotes growth. This raises the possibility that the growth 
of the salivary glands causes them to outcompete adult tissues for resources. While this 
possibility is still suggestive of defective resource allocation, it clouds autophagy’s 
potential role in resource allocation during Drosophila development. An important 
experiment to address this issue is to test whether inducing autophagy in a Dp110 
background rescues the adult tissue growth defect. Another consequence of Dp110 
expression is the activation of Akt which is known to directly stimulate aerobic 
glycolysis (Elstrom et al., 2004). This could explain why tissue-specific expression of 
Dp110 appears to have a greater effect on organismal lactate levels than tissue-specific 
knockdown of atg genes (Figure 3-5). I would test this by inducing autophagy in a Dp110 
background and assaying for lactate. If Akt is directly stimulating glycolysis downstream 
of Dp110 expression in salivary glands, then I would expect lactate levels to still be 
elevated.   
It is becoming clear that autophagy is intimately linked with tumor cell 
metabolism. Certain oncogenes, such as Ras and Akt have been shown to stimulate 
metabolic reprogramming by increasing glucose uptake and glycolysis (Flier et al., 1987; 
Elstrom et al., 2004). These same oncogenes have also been shown to be negative 
regulators of autophagy (Berry and Baehrecke, 2007; Degtyarev et al., 2008). However, 
there is mounting evidence that Ras-mediated oncogenesis requires autophagy. 
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Autophagy is elevated in pancreatic cancer cell lines, and a model of Ras-driven PDAC 
progression is sensitive to inhibition of autophagy (Yang et al., 2011, 2014). 
Additionally, depletion of atg genes suppresses Ras-driven tumorigenesis of immortal 
baby mouse kidney epithelial (iBMK) cells through accumulation of damaged 
mitochondria and decreased oxidative phosphorylation (Guo et al., 2011). These results 
suggest that some Ras-driven tumors develop an addiction to autophagy for metabolic 
support. This is likely due to the ability of autophagy to remove damaged mitochondria 
and to maintain metabolic homeostasis. In contrast, it has also been shown that autophagy 
can suppress progression of Ras-induced lung tumors, and that loss of autophagy can 
cause increased glycolysis in these tumors (Guo et al., 2013). Combined, these results 
suggest that the role of autophagy in the metabolism of Ras-expressing cells is context 
dependent. Perhaps this context dependency is caused by differential signaling of the 
downstream Ras effectors. It could be possible that Ras primarily signals through the 
PI3K/Akt or Raf/ERK axes in tumors that are not reliant on autophagy. Whereas, in the 
tumors that are addicted to autophagy, Ras could primarily signal through the RalGEF-
Ral axis. Future studies could focus on teasing apart whether or not Ral provides a link 
between Ras and its autophagy addiction in certain contexts. 
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Conclusions  
Cancer is the second leading cause of death in the United States. Cancer often 
exhibits a metabolic reprogramming that supports cell growth and proliferation, and it has 
begun to be thought of as a metabolic disease. As such, the metabolic processes that 
contribute to a cancer’s continued survival are attractive therapeutic targets: deplete its 
power, kill the beast. Autophagy is a metabolic process that can either aid in a tumor 
cell’s survival or lead to its demise depending on the cell’s context. This makes 
autophagy a promising therapeutic target. Therefore, it is important to understand the 
regulation and function of autophagy in a variety of cell contexts. In this thesis, I present 
the first in vivo evidence for the regulation of autophagy by the oncogenic Ral GTPase 
and its effector, the exocyst. Furthermore, I show that Ral and the exocyst regulate 
autophagy in a context-dependent manner, challenging the current model for how the 
Ral/ exocyst effector complex regulates autophagy. I also demonstrate, for the first time, 
the extensive metabolic consequences of depleting autophagy in vivo. I give evidence for 
autophagy functioning in degrading tissues to maintain overall metabolic homeostasis 
and organismal well-being. This research highlights the importance of understanding how 
pathways regulate autophagy in different cell contexts and the metabolic outcomes of 
manipulating those pathways. Going forward, this knowledge will be useful in the study 
of autophagy as a therapeutic target. 
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Appendix 
List of biochemicals identified by metabolic profiling of whole animals at 24 hours 
after puparium formation. 
The mean values for the biochemicals listed are indicated. Biochemical values for each 
sample were normalized by Bradford protein concentration, then each biochemical was 
rescaled to set the median equal to 1, and finally, missing values were imputed with the 
minimum.  
 
Biochemical Name KEGG HMDB WT 
Atg18 
Ctrl 
Atg18 
Mut 
glycine C00037 HMDB00123  0.9951 1.0115 1.1198 
N-acetylglycine   HMDB00532  1.0123 1.0674 0.8248 
beta-hydroxypyruvate C00168 HMDB01352  0.7801 0.8818 0.7882 
serine C00065 HMDB00187  0.9412 1.1846 0.6915 
N-acetylserine   HMDB02931  1.1943 0.9810 0.5607 
homoserine C00263 HMDB00719  0.9920 0.9707 0.8523 
threonine C00188 HMDB00167  1.1555 1.0104 0.6761 
N-acetylthreonine C01118   1.5180 1.1813 0.5852 
asparagine C00152 HMDB00168  1.1697 0.8818 0.6246 
beta-alanine C00099 HMDB00056  1.1447 0.9757 0.9028 
3-ureidopropionate C02642 HMDB00026  0.7672 1.1990 1.8869 
N-acetyl-beta-alanine C01073   1.0877 1.0846 1.0834 
alanine C00041 HMDB00161  1.0569 0.9578 1.6687 
N-acetylaspartate (NAA) C01042 HMDB00812  1.1459 1.0823 0.6501 
glutamate C00025 HMDB03339  1.0132 1.0596 0.7821 
glutamine C00064 HMDB00641  1.0211 1.0088 0.5167 
gamma-aminobutyrate (GABA) C00334 HMDB00112  1.1171 0.7954 1.5374 
N-acetylglutamate C00624 HMDB01138  0.9773 1.0018 0.7177 
histidine C00135 HMDB00177  1.1351 0.7940 0.6655 
1-methylhistidine C01152 HMDB00001  1.1492 1.2310 0.9116 
histamine C00388 HMDB00870  1.4333 0.8781 0.2271 
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cadaverine C01672 HMDB02322  3.0611 0.7618 0.4303 
glutarate (pentanedioate) C00489 HMDB00661  1.3276 0.8130 0.9903 
diaminopimelate C00666 HMDB01370  0.4207 1.6621 1.5386 
lysine C00047 HMDB00182  1.1566 1.0394 0.6288 
2-aminoadipate C00956 HMDB00510  1.6096 1.0396 0.8692 
pipecolate C00408 HMDB00070  1.1033 1.2906 0.8177 
N-6-trimethyllysine C03793 HMDB01325  0.9716 0.9422 0.7822 
N6-acetyllysine C02727 HMDB00206  1.2820 1.1516 0.7554 
phenylalanine C00079 HMDB00159  1.1330 0.9748 0.8569 
tyrosine C00082 HMDB00158  1.7181 1.0207 0.7718 
dihydoxyphenylalanine (L-DOPA) C00355 HMDB00181  2.1155 1.3963 0.2063 
N-acetylphenylalanine C03519 HMDB00512  0.7979 1.4955 1.1753 
phenylacetylglycine C05598 HMDB00821  0.5955 0.5180 2.4198 
xanthurenate C02470 HMDB00881  1.7653 0.9524 0.0505 
kynurenate C01717 HMDB00715  1.2353 0.7946 0.2197 
kynurenine C00328 HMDB00684  1.1384 1.0518 0.1252 
tryptophan C00078 HMDB00929  1.1582 1.0525 0.6437 
3-hydroxykynurenine C02794 HMDB00732  2.8295 1.0720 0.0294 
N-acetyltryptophan C03137   0.9339 1.2964 1.2629 
3-methyl-2-oxovalerate C00671 HMDB03736  0.8992 1.2017 0.8264 
alpha-hydroxyisocaproate C03264 HMDB00746  0.9738 0.9949 1.1222 
isoleucine C00407 HMDB00172  1.0222 1.0024 0.9532 
leucine C00123 HMDB00687  1.0935 1.0224 0.8414 
valine C00183 HMDB00883  1.0776 1.0454 0.9121 
4-methyl-2-oxopentanoate C00233 HMDB00695  0.8746 1.3325 0.7705 
3-hydroxy-2-ethylpropionate   HMDB00396  1.5298 1.0918 0.3043 
alpha-hydroxyisovalerate   HMDB00407  1.1856 0.7334 0.7058 
2-hydroxy-3-methylvalerate   HMDB00317  1.0992 0.9411 0.9827 
3-methylglutarylcarnitine (C6)   HMDB00552  0.8778 0.9480 2.3428 
cysteine C00097 HMDB00574  1.1414 1.2433 0.9539 
methionine sulfoxide C02989 HMDB02005  0.9676 1.0339 0.8012 
taurine C00245 HMDB00251  1.2021 1.1148 0.4683 
methionine C00073 HMDB00696  1.1659 0.8767 0.7217 
N-acetylmethionine C02712 HMDB11745  1.0736 0.9246 0.5601 
2-hydroxybutyrate (AHB) C05984 HMDB00008  0.7197 1.3921 0.9769 
homocysteine C00155 HMDB00742  1.0049 1.1078 0.8641 
assymetric dimethylarginine (ADMA) C03626 HMDB01539  1.0708 1.2065 0.7364 
arginine C00062 HMDB00517  1.0482 1.0490 0.5658 
N-acetylarginine C02562 HMDB04620  0.9210 1.1824 0.5513 
ornithine C00077 HMDB03374  1.3189 0.9782 1.0404 
urea C00086 HMDB00294  1.3784 0.9219 0.9706 
145 
 
proline C00148 HMDB00162  1.0514 0.8945 1.1510 
5-aminovalerate C00431 HMDB03355  1.6163 0.8947 0.2820 
trans-4-hydroxyproline C01157 HMDB00725  1.0745 1.0755 1.0058 
argininosuccinate C03406 HMDB00052  0.8260 0.8407 1.4975 
1,3-diaminopropane C00986 HMDB00002  0.3878 0.9182 0.3771 
N-delta-acetylornithine*     1.7828 1.0316 0.8702 
2-aminobutyrate C02261 HMDB00650  1.0888 1.2875 0.3201 
5-methylthioadenosine (MTA) C00170 HMDB01173  0.9553 1.2130 1.0936 
putrescine C00134 HMDB01414  1.3016 0.8246 0.3162 
agmatine C00179 HMDB01432  1.5867 1.2780 0.4133 
spermidine C00315 HMDB01257  1.3118 0.9627 0.7016 
4-guanidinobutanoate C01035 HMDB03464  1.2081 0.8956 1.9427 
5-oxoproline C01879 HMDB00267  0.9984 1.0187 0.7683 
N-methylalanine C02721 HMDB01906  1.0772 1.2329 0.9209 
glycylvaline     1.1109 1.1534 0.7861 
glycylproline   HMDB00721  1.1942 0.9889 0.8835 
glycylisoleucine     1.1290 1.1459 0.7615 
glycylleucine C02155 HMDB00759  0.9992 1.2274 0.5771 
glycylphenylalanine     1.1629 1.1411 0.8736 
glycyltryptophan     1.3342 1.1719 0.4485 
pro-hydroxy-pro   HMDB06695  1.2395 0.9563 1.2751 
prolylglutamate     1.1459 0.9037 0.9973 
gamma-glutamylvaline   HMDB11172  1.5756 2.0965 0.8676 
gamma-glutamylleucine   HMDB11171  1.0583 0.9131 0.9680 
gamma-glutamylmethionine     0.7174 2.8810 3.2907 
gamma-glutamylglutamate     1.2248 1.2232 0.8432 
gamma-glutamylphenylalanine   HMDB00594  0.9410 1.1071 0.9332 
N-acetylgalactosamine C01074 HMDB00212  0.9380 1.2205 0.8195 
N-acetylglucosamine C00140 HMDB00215  0.8751 0.9035 1.2194 
N-acetylglucosamine 6-phosphate C00357 HMDB02817  1.0968 1.0293 1.2079 
erythronate*   HMDB00613  1.0001 0.9742 1.4735 
Isobar: UDP-acetylglucosamine, UDP-
acetylgalactosamine 
    1.1505 1.0666 0.7689 
fructose C00095 HMDB00660  0.9603 0.6901 3.5802 
isomaltose C00252 HMDB02923  1.1287 0.9285 0.8254 
maltose C00208 HMDB00163  1.1136 0.9721 0.6648 
mannitol C00392 HMDB00765  1.2174 0.4806 0.5277 
mannose C00159 HMDB00169  0.9931 0.8829 1.3577 
mannose-6-phosphate C00275 HMDB01078  0.7671 1.1295 0.7585 
sorbitol C00794 HMDB00247  0.9584 0.7624 20.4532 
sorbose C00247 HMDB01266  1.1512 0.7837 0.4403 
146 
 
trehalose C01083 HMDB00975  0.9712 0.8590 1.1636 
maltotriose C01835 HMDB01262  1.1354 1.0055 0.8044 
maltotetraose C02052 HMDB01296  1.0463 1.0182 0.6419 
maltopentaose C06218 HMDB12254  0.8273 1.1949 0.7811 
maltohexaose C01936 HMDB12253  0.7292 1.4362 0.8905 
trehalose 6-phosphate C00689 HMDB01124  1.4978 0.6545 0.4875 
glycerate C00258 HMDB00139  1.4416 1.0568 0.7986 
glucose-6-phosphate (G6P) C00668 HMDB01401  0.7324 1.2785 0.8837 
glucose 1-phosphate C00103 HMDB01586  0.9271 1.1012 0.8142 
glucose C00031 HMDB00122  1.0904 0.9930 0.8677 
fructose-6-phosphate C05345 HMDB00124  0.7877 1.1516 0.8296 
3-phosphoglycerate C00597 HMDB00807  1.2895 0.8235 0.8896 
pyruvate C00022 HMDB00243  1.4590 1.0945 1.5052 
lactate C00186 HMDB00190  1.1753 1.0341 2.3800 
arabitol C00474 HMDB01851  4.5632 0.9368 0.7839 
ribitol C00474 HMDB00508  1.8590 0.8225 2.2617 
threitol C16884 HMDB04136  1.0877 0.8838 0.9027 
sedoheptulose-7-phosphate C05382 HMDB01068  1.2835 1.1297 0.7297 
gluconate C00257 HMDB00625  1.0288 1.0892 0.5804 
ribose C00121 HMDB00283  1.2946 1.2780 0.6511 
ribulose C00309 HMDB00621  1.7413 0.7684 2.2177 
Isobar: ribulose 5-phosphate, xylulose 5-
phosphate 
    1.2641 1.0983 0.2264 
UDP-glucuronate C00167 HMDB00935  1.1950 0.9108 1.0848 
xylitol C00379 HMDB02917  1.1272 1.2184 0.7307 
xylose C00181 HMDB00098  0.8423 1.0426 0.9052 
xylonate C05411   0.9493 1.1334 0.7480 
xylulose C00310 HMDB00654  1.4980 1.4360 0.4756 
UDP-glucose (isobar with UDP-galactose) C00029 HMDB00286  1.0542 1.7348 0.2990 
citrate C00158 HMDB00094  0.9199 1.1289 0.8363 
tricarballylate C19806   1.0480 0.4866 0.4090 
alpha-ketoglutarate C00026 HMDB00208  1.3515 1.1555 0.9746 
succinate C00042 HMDB00254  1.2552 1.0393 1.3334 
fumarate C00122 HMDB00134  0.8274 1.0574 1.1891 
malate C00149 HMDB00156  0.7284 0.9513 1.3285 
phosphate C00009 HMDB01429  1.1376 1.0703 0.9042 
pyrophosphate (PPi) C00013 HMDB00250  1.4666 1.1380 0.7830 
linoleate (18:2n6) C01595 HMDB00673  0.9007 0.9154 1.3052 
linolenate [alpha or gamma; (18:3n3 or 6)] C06427 HMDB01388  0.9262 0.8843 1.1586 
3-methyladipate   HMDB00555  0.8191 0.9112 0.8656 
caprate (10:0) C01571 HMDB00511  0.9260 1.0503 0.9286 
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laurate (12:0) C02679 HMDB00638  0.9724 0.9979 0.9550 
5-dodecenoate (12:1n7)   HMDB00529  0.8600 0.9539 1.1504 
myristate (14:0) C06424 HMDB00806  1.0572 0.9447 0.9459 
myristoleate (14:1n5) C08322 HMDB02000  1.0089 0.9037 1.1481 
pentadecanoate (15:0) C16537 HMDB00826  1.0014 1.0809 0.8791 
palmitate (16:0) C00249 HMDB00220  1.1795 1.0650 0.8759 
palmitoleate (16:1n7) C08362 HMDB03229  0.9772 0.8427 1.1724 
margarate (17:0)   HMDB02259  1.0827 1.0376 0.9566 
10-heptadecenoate (17:1n7)     0.9514 0.9242 1.1692 
stearate (18:0) C01530 HMDB00827  1.2307 0.9727 0.8075 
oleate (18:1n9) C00712 HMDB00207  1.0600 0.9688 1.3715 
cis-vaccenate (18:1n7) C08367   1.0880 0.9571 1.0326 
nonadecanoate (19:0) C16535 HMDB00772  0.9345 0.8168 1.6339 
eicosenoate (20:1n9 or 11)   HMDB02231  1.2016 0.9176 1.0294 
erucate (22:1n9) C08316 HMDB02068  1.2252 2.4080 1.2746 
3-hydroxypropanoate C01013 HMDB00700  1.1862 0.8769 1.2062 
adipate C06104 HMDB00448  1.0350 0.8039 2.3555 
2-hydroxyglutarate C02630 HMDB00606  0.9507 0.8731 1.5183 
4-hydroxy-2-oxoglutaric acid C01127 HMDB02070  1.4949 1.2095 0.8008 
tetradecanedioate   HMDB00872  0.9984 0.8077 3.6526 
hexadecanedioate   HMDB00672  1.1729 0.9040 3.1080 
2-aminooctanoate   HMDB00991  2.4864 0.8553 0.7751 
13-methylmyristic acid     1.5164 0.9682 0.7457 
15-methylpalmitate (isobar with 2-
methylpalmitate) 
    1.7126 1.0788 0.7582 
17-methylstearate     1.4722 1.1614 0.9257 
butyrylcarnitine C02862 HDMB02013  1.1952 0.8305 1.4091 
deoxycarnitine C01181 HMDB01161  1.0650 1.1970 0.2875 
carnitine C00318   1.0815 1.0709 0.8244 
3-dehydrocarnitine* C02636 HMDB12154  1.1431 0.9862 1.0619 
acetylcarnitine C02571 HMDB00201  0.9785 1.0107 0.9210 
palmitoylcarnitine C02990 HMDB00222  1.5407 1.3166 0.8390 
stearoylcarnitine   HMDB00848  1.6708 1.7835 0.6693 
oleoylcarnitine   HMDB05065  1.6092 1.4382 0.7928 
choline phosphate C00588   1.2167 1.0368 0.5783 
ethanolamine C00189 HMDB00149  1.4896 0.8733 1.0103 
phosphoethanolamine C00346 HMDB00224  1.0941 1.0781 0.7407 
glycerophosphoethanolamine C01233 HMDB00114  0.9699 1.8782 0.8777 
glycerol C00116 HMDB00131  1.1192 0.9841 0.9030 
glycerol 3-phosphate (G3P) C00093 HMDB00126  1.3412 0.9973 0.7216 
glycerophosphorylcholine (GPC) C00670 HMDB00086  0.7261 1.2921 1.1878 
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myo-inositol C00137 HMDB00211  1.3422 0.8887 0.7715 
inositol 1-phosphate (I1P) C04006 HMDB00213  1.1402 1.0084 0.5180 
3-hydroxybutyrate (BHBA) C01089 HMDB00357  1.0008 0.9465 1.4902 
1-myristoylglycerophosphoethanolamine   HMDB11500  0.7663 0.8108 2.9773 
2-myristoylglycerophosphoethanolamine*     0.9160 0.7122 2.2549 
1-palmitoylglycerophosphoethanolamine   HMDB11503  0.7989 0.8143 1.7273 
2-palmitoylglycerophosphoethanolamine*     0.8424 0.8186 1.6759 
1-
palmitoleoylglycerophosphoethanolamine* 
    0.9857 0.6308 1.9924 
2-
palmitoleoylglycerophosphoethanolamine* 
    1.8207 0.7587 0.9923 
1-stearoylglycerophosphoethanolamine   HMDB11130  1.0010 0.9355 1.7886 
1-oleoylglycerophosphoethanolamine   HMDB11506  1.1641 0.6462 1.4586 
2-oleoylglycerophosphoethanolamine*     2.1623 0.9058 0.6280 
1-linoleoylglycerophosphoethanolamine*   HMDB11507  1.2659 0.7704 1.2281 
2-linoleoylglycerophosphoethanolamine*     2.6197 1.1890 0.5498 
1-myristoylglycerophosphocholine (14:0)   HMDB10379  0.9569 0.9811 1.4759 
1-palmitoylglycerophosphocholine (16:0)     1.3828 1.0689 1.0038 
2-palmitoylglycerophosphocholine*     1.9358 1.0545 0.7815 
1-palmitoleoylglycerophosphocholine 
(16:1)* 
    1.1450 0.9504 1.3492 
2-palmitoleoylglycerophosphocholine*     2.8778 1.2383 0.6902 
1-stearoylglycerophosphocholine (18:0)     1.3691 1.0550 1.2239 
1-oleoylglycerophosphocholine (18:1)     1.4405 0.8655 1.1529 
2-oleoylglycerophosphocholine*     2.5668 1.2875 0.5989 
1-linoleoylglycerophosphocholine 
(18:2n6) 
C04100   1.7884 1.2563 0.9186 
2-linoleoylglycerophosphocholine*     3.0128 1.9378 0.3747 
1-palmitoylglycerophosphoinositol*     1.0501 1.0406 0.8804 
1-palmitoleoylglycerophosphoinositol*     1.7565 0.8919 0.7355 
2-palmitoleoylglycerophosphoinositol*     2.1406 0.9362 0.5680 
1-stearoylglycerophosphoinositol     0.9730 0.9945 1.2341 
1-oleoylglycerophosphoinositol*     1.0627 0.7505 1.0449 
1-linoleoylglycerophosphoinositol*     1.7737 1.0349 0.5719 
2-linoleoylglycerophosphoinositol*     2.3756 1.2482 0.3598 
2-oleoylglycerophosphoinositol*     1.8934 1.0226 0.4977 
1-oleoylglycerophosphoserine     1.4871 0.9562 0.7253 
2-oleoylglycerophosphoserine*     2.1209 1.2511 0.3354 
1-palmitoylplasmenylethanolamine*     0.7178 0.8081 1.4458 
1-linoleoylglycerophosphoserine*     1.9440 1.2608 0.4355 
1-oleoylglycerol (1-monoolein)   HMDB11567  1.2346 0.9549 1.0036 
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sphinganine C00836 HMDB00269  1.3251 1.7717 0.4745 
3-hydroxy-3-methylglutarate C03761 HMDB00355  1.1504 0.8966 0.9247 
beta-sitosterol C01753 HMDB00852  0.9735 1.0560 0.9042 
stigmasterol C05442 HMDB00937  1.1420 1.1047 0.8128 
campesterol C01789 HMDB02869  1.0013 1.1372 0.8258 
ergosterol C01694 HMDB00878  1.1224 1.0524 0.7652 
xanthine C00385 HMDB00292  0.9374 1.0840 0.8319 
xanthosine C01762 HMDB00299  1.1528 1.1010 0.3035 
hypoxanthine C00262 HMDB00157  0.8831 1.1142 0.7678 
inosine C00294 HMDB00195  0.9576 1.0269 0.9825 
2'-deoxyinosine C05512 HMDB00071  0.9920 1.1661 0.6467 
adenine C00147 HMDB00034  0.9298 1.0216 1.2784 
adenosine C00212 HMDB00050  0.9227 0.9217 1.3571 
1-methyladenine C02216 HMDB11599  1.1496 0.9891 0.8515 
N1-methyladenosine C02494 HMDB03331  1.7610 1.0657 0.2004 
adenosine 5'-monophosphate (AMP) C00020 HMDB00045  0.9094 0.8808 1.3585 
adenylosuccinate C03794 HMDB00536  0.7450 0.8236 1.8516 
N2,N2-dimethylguanine     1.3512 1.2006 0.4798 
guanosine C00387 HMDB00133  1.0951 1.0435 0.7087 
2'-deoxyguanosine C00330 HMDB00085  1.1005 1.1032 0.2564 
guanosine-2',3'-cyclic monophosphate C06194 HMDB11629  1.2007 1.2168 0.8406 
N1-methylguanosine   HMDB01563  1.3938 1.0991 0.4149 
N6-carbamoylthreonyladenosine     1.2184 1.0269 0.7784 
urate C00366 HMDB00289  1.1997 1.1408 0.6715 
allantoin C02350 HMDB00462  1.0048 0.5531 4.5617 
cytidine C00475 HMDB00089  1.0532 0.9838 0.3075 
cytidine 5'-monophosphate (5'-CMP) C00055 HMDB00095  1.0884 1.0669 0.6290 
cytosine-2',3'-cyclic monophosphate C02354 HMDB11691  1.2233 0.9967 1.2229 
orotate C00295 HMDB00226  1.0397 0.9599 1.2139 
3-aminoisobutyrate C05145 HMDB03911  1.1671 1.3046 0.4771 
uracil C00106 HMDB00300  1.2690 1.2312 0.6818 
5,6-dihydrouracil C00429 HMDB00076  0.7522 0.8485 1.6494 
uridine C00299 HMDB00296  1.0654 1.0340 0.8713 
pseudouridine C02067 HMDB00767  1.2971 0.9513 0.4745 
uridine monophosphate (5' or 3')   HMDB00288  1.5018 1.1116 0.6345 
uridine-2',3'-cyclic monophosphate C02355 HMDB11640  1.1933 1.0601 0.9948 
methylphosphate     1.0772 0.9457 0.9356 
threonate C01620 HMDB00943  1.0729 1.1077 1.0183 
arabonate   HMDB00539  1.0597 0.9531 0.9351 
biotin C00120 HMDB00030  1.0368 0.9755 0.7387 
biopterin C06313 HMDB00468  1.1723 0.9902 1.1718 
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dihydrobiopterin C00268 HMDB00038  1.8864 1.0501 0.7146 
isoxanthopterin C03975 HMDB00704  1.5133 1.2005 0.9406 
pterin C00715 HMDB00802  1.6962 1.0738 0.3552 
biliverdin C00500 HMDB01008  1.1475 1.0883 0.2236 
nicotinamide C00153 HMDB01406  0.9200 0.9910 1.3102 
nicotinamide ribonucleotide (NMN) C00455 HMDB00229  0.7911 0.9657 1.2300 
nicotinamide adenine dinucleotide 
(NAD+) 
C00003 HMDB00902  1.1817 0.9325 1.0006 
nicotinamide adenine dinucleotide reduced 
(NADH) 
C00004 HMDB01487  0.4749 0.6492 9.8460 
nicotinamide riboside* C03150 HMDB00855  1.1870 1.0936 0.5943 
6-hydroxynicotinate C01020 HMDB02658  0.9428 1.0230 0.2854 
nicotinate C00253 HMDB01488  1.1140 1.0197 0.4588 
nicotinurate C05380 HMDB03269  1.2354 1.1969 0.6845 
pantothenate C00864 HMDB00210  1.1693 1.1067 0.8198 
2,3-dihydroxyisovalerate C04039   0.8623 0.7773 0.6288 
pyridoxate C00847 HMDB00017  1.0815 0.9659 0.6684 
flavin adenine dinucleotide (FAD) C00016 HMDB01248  0.9382 0.8717 2.5537 
riboflavin (Vitamin B2) C00255 HMDB00244  1.3567 1.1896 0.3047 
thiamin (Vitamin B1) C00378   1.0906 1.0607 0.3676 
alpha-tocopherol C02477 HMDB01893  0.7220 1.0210 0.9093 
glycolate (hydroxyacetate) C00160 HMDB00115  1.1456 1.3596 0.6959 
glycerol 2-phosphate C02979 HMDB02520  1.0890 0.9660 1.0590 
methyl-alpha-glucopyranoside C02603   1.1443 1.0157 0.8138 
alpha-cyclodextrin     0.3942 0.6736 2.9975 
erythritol C00503 HMDB02994  1.0029 1.0027 1.8264 
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